S (2010-2018)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2018

+Studies in 2000-2009 List
*Studies in Pre-2000 List
>Information in Another Section

SAFETY AS A SUBSTANCE*+
SAFETY-ADULTERANTS/CONTAMINANTS*+
SALIVARY GLANDS/SALIVA
>SCHINZEL-GIEDION SYNDROME (See News Articles 2010-2018)
SCHISTOSOMA INFECTION +
SCHIZOPHRENIA/MENTAL DISORDERS*+
SCLERODERMA +
SEBACEOUS GLANDS + (Produce Skin Oils)
SEBORRHEA
SEPTIC SHOCK/SEPSIS/ENDOTOXEMIA*+
SEXUAL ABUSE

>SHINGLES (See News Articles 2010-2018)
SICKLE CELL DISEASE +
>SINUSITIS (See 2000-2009)
SKIN

SLEEP APNEA +
SLEEPING SICKNESS/TRYPANOSOMIASIS* (See Also CHAGAS DISEASE)
SLEEP MODULATION*+
SMALLPOX + (See Also COW POX [not good news])
SMELL/ODOR DETECTION +
SMOKED CANNABIS AS A MEDICATION*+ (See Also METHODS OF USE-SMOKING)
SOCIAL ADJUSTMENT/BEHAVIOR*+
SOCIAL ANXIETY

SOCIAL MEDIA/INTERNET
SPACEFLIGHT/OUTER SPACE
SPASTICITY*+
SPINAL CORD INJURY*+
SPINOCEREBELLAR ATAXIA/SCA (Inherited Neurodegenerative Disorder. See Also ATAXIA)
SPLEEN*+
SPORTS (see Also EXERCISE)
STEM CELLS +
STIFF-PERSON SYNDROME/HYPEREKPLEXIA DISEASE +
STORAGE of CANNABIS/CANNABINOIDS (Most Are Old, But Questions On Storage Come Up Often!)
STRAIN INFORMATION (Until Researchers Pay Attention To What Strains They Are Using, They Will Never Get Consistent Results!)
STRESS + (See Also ANXIETY, POST TRAUMATIC STRESS DISORDER)
STROKE*+ (See Also PERINATAL HYPOXIC-ISCHEMIC INJURY)
STURGE-WEBER SYNDROME (Causes Vascular Malformations, Epilepsy, Strokes and Retardation)

STUTTERING + (See Also News Articles 2010-2018)
SUICIDE +
SYSTEMIC MASTOCYTOSIS
SYSTEMIC SCLEROSIS
top


SAFETY AS A SUBSTANCE*+
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant for administration by ingestion or other means (Health Canada) (full–2010) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Summary of Product Characteristics- Sativex Oralmucosal Spray (full–2010)  http://www.medicines.org.uk/EMC/medicine/23262/SPC/Sativex+Oromucosal+Spray/
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people  with multiple sclerosis (link to download-2010)  https://www.researchgate.net/publication/44683223_Metaanalysis_of_the_efficacy_and_safety_of_Sativex_nabiximols_on_spasticity_in_people_with_multiple_sclerosis
Drug Harms in the UK (full–2010) http://www.scribd.com/doc/41349905/Alcohol-Lancet-2010
Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use (abst–2010)
http://www.ncbi.nlm.nih.gov/pubmed/20565525
Ocular Hypotensive Efficacy and Safety of Oral Palmytoilethanolamide (Visimast®): Clinical Study (abst–2010) http://iovs.arvojournals.org/article.aspx?articleid=2369941&resultClick=1
An index of fatal toxicity for drugs of misuse (abst-2010)  http://www.ncbi.nlm.nih.gov/pubmed/20104506
A summary of the health harms of drugs – Section 5 Cannabis (full–2011) http://www.nta.nhs.uk/uploads/healthharmsfinal-v1.pdf
Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent (full-2011) http://www.medicinalgenomics.com/wp-content/uploads/2013/01/Bergamaschi_2011.pdf
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Cannabinoid effects on ventilation and breathlessness: A pilot study of efficacy and safety (link to download–2011) http://journals.sagepub.com/doi/abs/10.1177/1479972310391283
Annual Causes of Death in the United States (article–2011) http://drugwarfacts.org/cms/?q=node/30
Health effects of using cannabis for therapeutic purposes: a gender analysis of users’  perspectives (abst in English, French & Spanish–2011)  http://www.tandfonline.com/doi/abs/10.3109/10826084.2010.537732?journalCode=isum20
Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites  in urine (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/20634020/abstract/Prolonged_coma_in_a_child_due_to_hashish_ingestion_with_quantitation_of_THC_metabolites_in_urine_
Prescribing Cannabis for Harm Reduction (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-1.pdf
Medical Marijuana: Clearing Away the Smoke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
Synthetic cannabinoid and marijuana exposures reported to poison centers (full–2012) http://journals.sagepub.com/doi/full/10.1177/0960327111421945
Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716148
Evaluation of the safety and tolerability profile of Sativex: is it reassuring enough? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22509986
Acute cannabis poisoning in a 10-month-old infant (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22652516
Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized controlled Trial Results (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22367503
Marijuana: modern medical chimaera (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22873011
Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the  cannabinoids [Health Canada, 2013] (full–2013) http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107777/
The pharmacologic and clinical effects of medical cannabis (full–2013) https://www.scribd.com/document/255637575/The-Pharmacologic-and-Clinical-Effects-of-Medical-Cannabis
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945037/
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review (full–2013)
http://www.tandfonline.com/doi/full/10.3109/03602532.2013.849268
The Future of Marijuana in the United States (download-thesis–2013)  https://scholarsbank.uoregon.edu/xmlui/handle/1794/13615
Anticipated Medical Effects on Children From Legalization of Marijuana in Colorado and Washington State (abst+1st page–2013) http://archpedi.jamanetwork.com/article.aspx?articleid=1691419&resultClick=3
Endocannabinoid system modulator use in everyday clinical practice in the UK and Spain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
Physical harm due to chronic substance use (abst–2013) http://www.sciencedirect.com/science/article/pii/S0273230013000457
Systematic review of the literature on clinical and experimental trials on the antitumor  effects of cannabinoids in gliomas (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24142199
Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A  time series analysis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23867051
Does smoking marijuana cause stroke? (abst–2013)  http://www.thepoisonreview.com/2013/01/26/does-smoking-marijuana-cause-stroke/
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations (full–2014) http://www.cfp.ca/content/60/12/1083.long
Physicians as gatekeepers in the use of medical marijuana (full–2014) http://www.jaapl.org/content/39/4/460.long
The Legalization of Marijuana in Colorado: The Impact. Rocky Mountain HIDTA. The Impact (full–2014) http://www.rmhidta.org/html/August%202014%20Legalization%20of%20MJ%20in%20Colorado%20the%20Impact.pdf
Inhaled medicinal cannabis and the immuno-compromised patient (full–2014) MASSC
Cannabidiol: Promise and Pitfalls (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189631/
The Oral Cannabis Poisoning of the Child (About 36 Cases) (full–2014)  https://www.omicsonline.org/open-access/the-oral-cannabis-poisoning-of-the-child-about-cases-2150-3494.1000086.php?aid=29927%253Fabstract_id=29927
Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress  Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other  Indications: A Retrospective Evaluation (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165471/
Big Marijuana — Lessons from Big Tobacco (link to download–2014)  http://www.mentalhealthportland.org/wp-content/uploads/2014/09/Big-Marijuana-%e2%80%94-Lessons-from-Big-Tobacco.pdf
A new method of cannabis ingestion: The dangers of dabs? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24930049
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24943098

Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25035121
Re-branding cannabis: the next generation of chronic pain medicine? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25537695
EFFICACY AND SAFETY OF EPIDIOLEX (CANNABIDIOL) IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY: INITIAL DATA FROM AN EXPANDED ACCESS PROGRAM (abst–2014)  https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868751#sthash.pbnOqzNG.dpuf

THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868391#sthash.uxbwgudh.dpuf
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
top
The cannabis conundrum: Thinking outside the THC box (full–2015) https://www.researchgate.net/publication/274726629_The_cannabis_conundrum_Thinking_outside_the_THC_box_The_Cannabis_Conundrum_Thinking_Outside_the_THC
Notes from the Field: Death Following Ingestion of an Edible Marijuana Product-Colorado, March 2014 (full–2015) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6428a6.htm
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development (full–2015) http://www.hindawi.com/journals/ecam/2015/238482/
Mull it over: cannabis vaporizers and harm reduction (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13139/full
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456813/
Cannabinoids in the management of chronic pain: a front line clinical perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0059/jbcpp-2015-0059.xml
Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361312/
Cannabis Allergy: What do We Know Anno 2015 (full–2015) http://link.springer.com/article/10.1007%2Fs00005-015-0352-z
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/
Responsible and controlled use: Older cannabis users and harm reduction (full–2015) http://www.ijdp.org/article/S0955-3959(15)00075-4/fulltext
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9- tetrahydrocannabinol in older persons with dementia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480847/
Marijuana: A Time-Honored but Untested Treatment for Epilepsy (full–2015) https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences/article/divclasstitlemarijuana-a-time-honored-but-untested-treatment-forepilepsydiv/DDEDDD9EAA09918D3D69CC7CA047AE5C/core-reader
Phytocannabinoids and epilepsy (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12235/full
Cannabinoids and Epilepsy (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0375-5
Safety of oral dronabinol during opioid withdrawal in humans (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663169/
Narrative review of the safety and efficacy of marijuana for the treatment of commonly
state-approved medical and psychiatric disorders (full–2015)  http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A  systematic review of randomized controlled trials (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/acr.22727/full
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS) (full–2015) http://www.jpain.org/article/S1526-5900(15)00837-8/fulltext
Half-Baked — The Retail Promotion of Marijuana Edibles (article–2015)  http://www.nejm.org/doi/full/10.1056/NEJMp1416014
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is
seldom clear-cut (article–2015)  http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full
Peaceful feeling, or up in smoke? Medical marijuana in medicolegal context (article–2015)  http://www.beyondthebrain.net/blog/peaceful-feeling-or-up-in-smoke-medical-marijuana-in-medicolegal-context
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881115574493
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial (abst–2015) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2815%2900379-8/abstract
European rating of drug harms (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/25922421

top
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/nl9g6x6
A safer alternative: Cannabis substitution as harm reduction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25919477
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study (abst–2015) http://link.springer.com/article/10.1007/s10072-015-2392-x
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the
modulation of distinct panic-like responses (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/25601395
Medicinal cannabis in Australia: the missing links (full–2016)  https://pdfs.semanticscholar.org/0a78/2bc09cea4e52007a16bd725ec3bee51e80b2.pdf
Merck Manual – Marijuana (Cannabis) Professional version (full–2016) http://www.merckmanuals.com/professional/special-subjects/recreational-drugs-and-intoxicants/marijuanacannabis
Merck Manual – Marijuana (Cannabis) Consumer version (full–2016) http://www.merckmanuals.com/home/special-subjects/recreational-drugs-and-intoxicants/marijuana
Cannabinoids for pediatric epilepsy? Up in smoke or real science? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729003/
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers (full–2016) http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience (full–2016) http://www.seizure-journal.com/article/S1059-1311(16)00005-4/fulltext
Is the medical use of cannabis a therapeutic option for children? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758425/
Associations Between Cannabis Use and Physical Health Problems in Early Midlife (full–2016) http://archpsyc.jamanetwork.com/article.aspx?articleid=2526003
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to  marijuana? (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in  Electronic Cigarettes (full–2016)  http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of  Clinical Effectiveness, Safety, and Guidelines (full–2016)  https://www.ncbi.nlm.nih.gov/books/NBK395789/
Medical cannabis use in Canada: vapourization and modes of delivery (full–2016)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0119-9
Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and  Interest Prior to Program Launch (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083080/
Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes  (full–2016) http://www.ijdp.org/article/S0955-3959(16)30334-6/fulltext
Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana (full–2016) http://www.tandfonline.com/doi/full/10.3109/00952990.2015.1135158
Marijuana: Medical Applications, Recreational Use and Substance Abuse Disorders (link to download–2016) http://www.eurekaselect.com/85221/article
Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway (link to PDF–2016)  http://jpet.aspetjournals.org/content/early/2016/05/18/jpet.116.232561.long
Evidence for Medicinal Use of Cannabis (article–2016) http://www.physio-pedia.com/Evidence_for_Medicinal_Use_of_Cannabis
Marijuana – How Safe is it Really? (article-link to PDF–2016)  https://journals.mcmaster.ca/iScientist/article/download/1104/991
Minimal Physical Health Risk Associated With Long-term Cannabis Use—But Buyer Beware (full–2016) http://jama.jamanetwork.com/article.aspx?articleid=2526619
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115

Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26757043
Chapter 5 – Quality Control and Stability Assessment (abst–2016)  http://www.sciencedirect.com/science/article/pii/B9780128046463000059
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A
systematic review of randomized controlled studies (abst in German & English-2016) http://link.springer.com/article/10.1007%2Fs00482-015-0089-y
Plant-Derived and Endogenous Cannabinoids in Epilepsy (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26892745
Cannabinoids: Medical implications (abst–2016)  http://www.tandfonline.com/doi/abs/10.3109/07853890.2016.1145794?journalCode=iann20
Cannabis – Position Paper of the German Respiratory Society (DGP) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935046
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain:  A Prospective Open-label Study (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26889611
Qualitative research in Spanish cannabis social clubs: “The moment you enter the door,  you are minimising the risks” (abst–2016)
http://www.ncbi.nlm.nih.gov/pubmed/27461986
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27579692
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst in German & English-2016) https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
State of the evidence: Cannabinoids and cancer pain-A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27863159
Could cannabidiol be used as an alternative to antipsychotics? (abst–2016)  http://www.journalofpsychiatricresearch.com/article/S0022-3956(16)30104-2/abstract
Evaluating the public health impacts of legalizing recreational cannabis use in the USA  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27082374
Why it is probably too soon to assess the public health effects of legalisation of  recreational cannabis use in the USA (abst–2016)  http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(16)30071-2/abstract
Attitudes to legalizing cannabis use (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27037958

Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)
https://www.ncbi.nlm.nih.gov/books/NBK65755/
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives (full–2017)
http://meetinglibrary.asco.org/record/140727/edbook#fulltext
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of
Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care
Setting (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/
Cannabinoids in Pediatrics (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent
Epilepsy? (full–2017) http://www.j-epilepsy.org/journal/view.php?year=2017&vol=7&page=16
top
Cannabis Users’ Recommended Warnings for Packages of Legally Sold Cannabis: An  Australia-Centered Study (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531364/
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569620/
The current status of artisanal cannabis for the treatment of epilepsy in the United States (full–2017)  https://www.projectcbd.org/sites/projectcbd/files/downloads/the_current_status_of_artisanal_cannabis_for_the_treatment_of_epilepsy_in_the_united_states.pdf
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis)
in Mexican Children with Refractory Epilepsy (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28392943
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions,  Possibilities, and Challenges (full–2017)  https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full
Vaping medical marijuana (full–2017)  http://www.tandfonline.com/doi/full/10.1080/00325481.2018.1413281
Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738750/
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last? (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767492/
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
The Use of Medical Cannabis with Other Medications: A Review of Safety and Guidelines [Internet] (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29293302
Benefits and Harms of Cannabis in Chronic Pain or Post-traumatic Stress Disorder: A  Systematic Review (full–2017)  https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0098113 /
Efficacy of Medical Cannabis for Treatment of Refractory Epilepsy in Children and  Adolescents with Emphasis on the Israeli Experience (link to PDF–2017)  https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4041
Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome  after Human Papillomavirus Vaccination (link to PDF–2017)  https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4042
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
A 10-year review of cannabis exposure in children under 3-years of age: do we need a  more global approach? (abst–2017) https://link.springer.com/article/10.1007%2Fs00431-017-2872-5
Pregnant Women’s Current and Intended Cannabis Use in Relation to Their Views  Toward Legalization and Knowledge of Potential Harm (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28252456
Can we make cannabis safer? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28259650
Carbonyl Compounds Produced by Vaporizing Cannabis Oil Thinning Agents (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28355118
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among  young adults in Colorado: Implications for health education and research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28449191
Marijuana Use in the Elderly: Implications and Considerations (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28595684
Pharmacologic Implications of Marijuana Use During Pregnancy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28599743
A little “dab” will do ya’ in: a case report of neuro-and cardiotoxicity following use of  cannabis concentrates (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28644052
Mapping medical marijuana: state laws regulating patients, product safety, supply chains
and dispensaries, 2017 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28696583
Occurrence of illicit drugs in water and wastewater, and their removal during wastewater treatment (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0043135417306413
Is there a role for cannabidiol in psychiatry? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28112021
Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review  and meta-analysis of randomized clinical trials (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28917371
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain  management – An overview of systematic reviews (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29034533
Sativex in the management of multiple sclerosis-related spasticity: An overview of the  last decade of clinical evaluation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29055461
Developmental effects of cannabidiol and Δ9-tetrahydrocannabinol in zebrafish (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29106691
Pharmacological Foundations of Cannabis Chemovars (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29161743
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28537982
Non-clinical toxicity of β-caryophyllene, a dietary cannabinoid: Absence of adverse  effects in female Swiss mice (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0273230017304014?via%3Dihub
Practical considerations in medical cannabis administration and dosing (abst–2017)  http://www.ejinme.com/article/S0953-6205(18)30004-9/fulltext
Cannabis Intoxication Case Series: The Dangers of Edibles Containing  Tetrahydrocannabinol (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29103798
Efficacy and safety of cannabis for treating children with refractory epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Contemporary Routes of Cannabis Consumption: A Primer for Clinicians (full–2018) http://jaoa.org/article.aspx?articleid=2671435
Cannabinoid Disposition After Human Intraperitoneal Use: An Insight Into  Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer (abst–2018)  http://www.clinicaltherapeutics.com/article/S0149-2918(17)31114-1/fulltext
A Reciprocal Effects Analysis of Cannabis Use and Perceptions of Risk (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29377544


SAFETY-ADULTERANTS/CONTAMINANTS*+
CUT, A Guide to the Adulterants, Bulking agents and other Contaminants found in illicit drugs (full–2010) http://www.cph.org.uk/publication/cut-a-guide-to-the-adulterants-bulking-agents-and-other-contaminants-found-in-illicit-drugs/
Too many mouldy joints – marijuana and chronic pulmonary aspergillosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103256/?tool=pubmed
Adding Tobacco to Cannabis–Its Frequency and Likely Implications (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21454910
Fatal alveolar haemorrhage following a “bang” of cannabis (abst in English, full in French–2011) http://www.em-consulte.com/rmr/article/651286/
Talcum induced pneumoconiosis following inhalation of adulterated marijuana, a case report (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348083/
Determination of pesticide residues in cannabis smoke (full–2013) https://www.hindawi.com/journals/jt/2013/378168/
Hemoptysis in a young man smoking cannabis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23619207
Potential exposures associated with indoor marijuana growing operations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24116667
Recurrent myopericarditis as a complication of Marijuana use (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921097/
Inhaled medicinal cannabis and the immunocompromised patient (full–2014) http://www.mascc.org/assets/Pain_Center/2015_March/march2015-11.pdf
Determination of Herbicides Paraquat, Glyphosate, and Aminomethylphosphonic Acid in Marijuana Samples by Capillary Electrophoresis (abst–2014) http://onlinelibrary.wiley.com/doi/10.1111/1556-4029.12628/full
Cannabis, Pesticides and Conflicting Laws: the Dilemma for Legalized States and Implications for Public Health (abst–2014) http://www.sciencedirect.com/science/article/pii/S027323001400097X
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Cannabis microbiome sequencing reveals several mycotoxic fungi native to dispensary
grade Cannabis flowers (full–2015)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897766/
Understanding dabs: contamination concerns of cannabis concentrates and cannabinoid transfer during the act of dabbing (link to PDF–2015) https://www.jstage.jst.go.jp/article/jts/40/6/40_797/_article
Dabble With Danger: A Case Of Severe Respiratory Failure Following Inhalation Of Butane Hash Oil (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4596
False hashish without cannabis resin (abst–2015) http://www.ingentaconnect.com/search/article?option1=title&value1=false+hashish&pageSize=10&index=1
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater Site in Abbottabad, Pakistan (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26366840
Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00108/full
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/ Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Metagenomic analysis of medicinal Cannabis samples; pathogenic bacteria, toxigenic fungi, and beneficial microbes grow in culture-based yeast and mold tests (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089129/
Analysis of a commerical marijuana e-cigarette formulation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867395/
Acute intoxication of four individuals following use of the synthetic cannabinoid MABCHMINACA (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27227269
Alveolar haemorrhage following a cannabis water pipe (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27421143
High Time to Assess the Environmental Impacts of Cannabis Cultivation (full–2017) http://pubs.acs.org/doi/full/10.1021/acs.est.6b06343
Identification of a Widespread Palmitoylethanolamide Contamination in Standard  Laboratory Glassware (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510777/
Expert Panel on Understanding Cannabis: Medicine, Society, Government (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657088/
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
Marijuana “bong” pseudomonas lung infection: a detrimental recreational experience  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756717/
Thermolytic degradation of synthetic cannabinoids: chemical exposures and  pharmacological consequences (link to download–2017)  http://jpet.aspetjournals.org/content/early/2017/01/13/jpet.116.238717.long
Endogenous synthesis of pyrethrins by cannabis (not all strains, just “Medihaze”, so far)  (link to PDF–2017) http://www.biorxiv.org/content/early/2017/07/28/169417
Into the void: Regulating pesticide use in Colorado’s commercial cannabis markets (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28173984
What Should We Tell Our Patients About Marijuana (Cannabis indica and Cannabis  sativa)? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28223891
Acute and residual effects in adolescent rats resulting from exposure to the novel  synthetic cannabinoids AB-PINACA and AB-FUBINACA (abst–2017)  http://journals.sagepub.com/doi/abs/10.1177/0269881116684336
Perceived harms and benefits of tobacco, marijuana, and electronic vaporizers among  young adults in Colorado: Implications for health education and research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28449191
The use of pesticides in Belgian illicit indoor cannabis plantations (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0379073817301871
Disseminated aspergillosis in an HIV-positive cannabis user taking steroid treatment  (abst–2017) http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30438-3/fulltext
How four U.S. states are regulating recreational marijuana edibles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28343113
Microbial hazards during harvesting and processing at an outdoor United States cannabis farm (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29370578
Cryptococcal meningitis in a daily cannabis smoker without evidence of  immunodeficiency (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29374632


SALIVARY GLANDS/SALIVA
Saliva of obese patients – is it different? (download–2015)  http://www.phmd.pl/fulltxt.php?ICID=1176778
The presence and distribution of cannabinoid type 1 and 2 receptors in the mandibular  gland: The influence of different physical forms of diets on their expression in piglets  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29218862
Immunohistochemical localization of cannabinoid receptor 1 (CB1) in the submandibular gland of mice under normal conditions and when stimulated by isoproterenol or carbachol (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28549258
Salivary endocannabinoids and N-acylethanolamines upon mastication of a semisolid
food: implications in fat taste, appetite and food liking (abst–2018)  http://pubs.rsc.org/en/Content/ArticleLanding/2018/FO/C7FO01772C#!divAbstract


SCHISTOSOMA INFECTION +
Effects of anandamide on proliferation of and pErk expression in primary hepatic stellate cells of schistosome-induced liver fibrosis mice (abst in English–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23663762 (abst in Chinese) http://zhgzbzz.yiigle.com/CN501113201301/189405.htm?locale=zh_CN
Upregulation of Cannabinoid Receptor-1 and Fibrotic Activation of Mouse Hepatic Stellate Cells during Schistosoma J. Infection: Role of NADPH Oxidase (abst–2014) http://www.sciencedirect.com/science/article/pii/S0891584914001324
top
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)  https://www.karger.com/Article/FullText/481824


SCHIZOPHRENIA/MENTAL DISORDERS*+
Mixed mood disorder (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/228/?pagenum=2
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/601/?pagenum=2
Do patients think cannabis causes schizophrenia? – A qualitative study on the causal beliefs of cannabis using patients with schizophrenia (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954921/?tool=pmcentrez
Reasons for illicit drug use in people with schizophrenia: Qualitative study (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2999587/?tool=pubmed
Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900481/?tool=pubmed
Therapeutical use of the cannabinoids in psychiatry (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500009&lng=en&nrm=iso&tlng=en
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055343/?tool=pubmed
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00144.x/full
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice (full–2010) http://ijnp.oxfordjournals.org/content/13/7/861.long
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283159/
Alterations in Metabotropic Glutamate Receptor 1a and Regulator of G Protein Signaling 4 in the Prefrontal Cortex in Schizophrenia (full-2010)  http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2010.10030318
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Endocannabinoids and Schizophrenia (full–2010)  http://www.mdpi.com/1424-8247/3/10/3101/htm
Does intravenous {triangleup}9-tetrahydrocannabinol increase dopamine release? A SPET study (link to download–2010)  https://www.researchgate.net/publication/46306066_Does_intravenous_D9-
tetrahydrocannabinol_increase_dopamine_release_A_SPET_study
Endocannabinoids and Schizophrenia (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3101
Endocannabinoids and psychiatric disorders: the road ahead (article–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516- 44462010000500003&lng=en&nrm=iso&tlng=en
Bad Mojo: use of the new marijuana substitute leads to more and more ED visits for acute psychosis (editorial–2010) http://www.ajemjournal.com/article/S0735-6757%2810%2900394-3/abstract
Tardive Dystonia and the Use of Cannabis (letter-forum repost-2010) http://www.420magazine.com/forums/dystonia/169902-tardive-dystonia-use-cannabis.html
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19854030
Brain cannabinoid CB2 receptor in schizophrenia (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19931854
Attraction to cannabis among men with schizophrenia: a phenomenological study (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20420097
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice (full–2011) http://www.nature.com/npp/journal/v36/n7/full/npp201134a.html
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use (full–2011) http://www.hindawi.com/journals/sprt/2011/501726/
Gadolinium-HU-308-incorporated micelles (full–2011) http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabis, COMT and psychotic experiences (full–2011) http://bjp.rcpsych.org/content/199/5/380.long
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186912/pdf/fnbeh-05-00063.pdf
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717343/
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085576/
Cannabis with high cannabidiol content is associated with fewer psychotic experiences (full–2011) http://www.schres-journal.com/article/S0920-9964%2811%2900224-6/fulltext
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (full–2011) http://www.lufg.com.au/files/media/Popular_intoxicants_what_lessons_can_be_learned.pdf
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids (full–2011) http://ijnp.oxfordjournals.org/content/14/5/631.long
top
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity  (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388033/
Bilateral testicular self-castration due to cannabis abuse: a case report (full–2011)  (warning- very graphic pictures) http://www.jmedicalcasereports.com/content/5/1/404
Greasing the wheels of managing overweight and obesity with omega-3 fatty acids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210336/
Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038245/
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (download-2011) [PDF] archives-ouvertes.fr
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain  (charts–2011) http://www.nature.com/neuro/journal/v14/n3/fig_tab/nn.2736_F1.html
Psychosis Associated With Synthetic Cannabinoid Agonists: A Case Series (letter–2011) http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2011.11010176
The endocannabinoid system in the regulation of emotions throughout lifespan: a  discussion on therapeutic perspectives (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21693551
Cannabis use predicts shorter duration of untreated psychosis and lower levels of  negative symptoms in first-episode psychosis: a South African study (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21390411
History of cannabis use is not associated with alterations in striatal dopamine D2/D3  receptor availability (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21890594
Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia (abst-2011) http://www.sciencedirect.com/science/article/pii/S0166432811002567
Synthetic cannabinoid JWH-018 and psychosis: An explorative study (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21316162/abstract/Synthetic_cannabinoid_JWH_018_and_psychosis:_An_explorative_study_
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0278584610004227
Endocannabinoid system dysfunction in mood and related disorders (abst–2011)
http://www.ncbi.nlm.nih.gov/pubmed/21916860
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like  symptoms and psychological well-being (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21798112
Association between a cannabinoid receptor gene (CNR1) polymorphism and  cannabinoid-induced alterations of the auditory event-related P300 potential (abst-2011) http://www.sciencedirect.com/science/article/pii/S030439401100437X?via%3Dihub
Prospective Study of Cannabis Use in Adolescents at Clinical High-Risk for Psychosis: Impact on Conversion to Psychosis and Functional Outcome (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459073/
Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong (full–2012) (full in English, abst in Chinese–2012)
http://www.easap.asia/index.php/component/k2/item/192-1202-v22n1-31-cr
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316151/?tool=pubmed
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317922/
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457074/
Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts (full–2012) http://www.biomedcentral.com/1471-244X/12/112
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392453/
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity (full–2012) http://link.springer.com/article/10.1007/s00213-012-2785-y/fulltext.html
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full-2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02175.x/full
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463751/
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351574/
Cortical basket cell dysfunction in schizophrenia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381305/
The endocannabinoid system and its role in schizophrenia: a systematic review of the literature (full-2012) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000600005&lng=en&nrm=iso&tlng=en
Investigating the interaction between schizotypy, divergent thinking and cannabis use  (full–2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657189/
The endocannabinoid system and its role in schizophrenia: a systematic review of the  literature (full–2012)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000600005&lng=en&nrm=iso&tlng=en
Genetic Variation Underlying Psychosis-inducing Effects of Cannabis: Critical Review and Future Directions (link to download–2012)  https://www.researchgate.net/publication/227707543_Genetic_Variation_Underlying_Psychosisinducing_Effects_of_Cannabis_Critical_Review_and_Future_Directions
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (link to PDF–2012)  https://www.researchgate.net/publication/232066502_Cannabidiol_inhibits_THC-elicited_paranoid_symptoms_and_hippocampaldependent_memory_impairment
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydro-cannabinol and Cannabidiol in Rodent Models of Schizophrenia (link to PDF–2012) http://www.eurekaselect.com/102848/article
A critical review of the antipsychotic effects of Cannabidiol: 30 years of a translational investigation. (link to PDF–2012) http://www.eurekaselect.com/102849/article
Medical use of cannabis. Cannabidiol: A new light for schizophrenia? (full-2012) http://onlinelibrary.wiley.com/doi/10.1002/dta.1425/full
Increased gray matter density in patients with schizophrenia and cannabis use: A voxel based morphometric study using DARTEL (abst–2012) http://www.sciencedirect.com/science/article/pii/S0920996412001740
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716146
Neurocognitive functioning and cannabis use in schizophrenia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716156
Anandamide dysfunction in prodromal and established psychosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716147
Subjective and Physiological Effects of Oromucosal Sprays Containing Cannabinoids (Nabiximols): Potentials and Limitations for Psychosis Research (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716155
Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice (abst–2012) http://www.springerlink.com/content/ur5784gm34782505/
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22920733
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22831980
The Effect of Cannabis on Perception of Time (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22716134
Synthetic cannabinoid use: recognition and management (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22418399
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544397/
Cannabis and psychosis: what causes what? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544398/
Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033548
An investigation into “two hit” effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice (full–2013) http://www.frontiersin.org/Journal/10.3389/fnbeh.2013.00149/full
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076635
“Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report (full-2013) http://onlinelibrary.wiley.com/doi/10.1002/hup.2312/full
Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by Facilitating the Degradation of Endocannabinoid 2-AG (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776056/
top
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors: implications for schizophrenia (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717536/
What does a mouse tell us about neuregulin 1-cannabis interactions? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581817/
Peripheral endocannabinoid system dysregulation in first-episode psychosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828529/
The role of cannabinoid 1 receptor expressing interneurons in behavior (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946968/
Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/acps.12108/full
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation (abst in English & German–2013)  https://link.springer.com/article/10.1007%2Fs40211-012-0045-3
top

CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373
A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers (abst–2013) http://www.sciencedirect.com/science/article/pii/S002839081200247X
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (abst–2013) http://link.springer.com/article/10.1007/s00213-012-2839-1
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23389966
Cigarette smoking and cannabis use are equally strongly associated with psychotic-like experiences: a cross-sectional study in 1929 young adults (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23414608
Psychosis and Severe Rhabdomyolysis Associated with Synthetic Cannabinoid Use (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23518784
Electroconvulsive Therapy (ECT) for Catatonia in a Patient With Schizophrenia and Synthetic Cannabinoid Abuse: A Case Report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23670023
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23800614
Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23846977
Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23867051
Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23906663
Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24219803
Fatty acid ethanolamide levels are altered in borderline personality and complex post-traumatic stress disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24253425
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750
Cannabidiol as a potential treatment for psychosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24309088
Hospitalisation associated with use of the synthetic cannabinoid K2 (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23831873
The vital role of constitutive GPCR activity in the mesolimbic dopamine system (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944632/
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuro-psychiatric disorders (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/
CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain neurotensin (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016688/
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915876/
top

Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409437/
A controlled family study of cannabis users with and without psychosis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319545/
Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid Dependent Long-Term Plasticity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023141/
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area (full–2014) http://www.jneurosci.org/content/34/39/13096.long
Acute administration of Δ9 tetrahydrocannabinol does not prevent enhancement of sensory gating by clozapine in DBA/2 mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945413/
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368886/
Genetic predisposition to schizophrenia associated with increased use of cannabis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382963/
Paranoid Personality Disorder in the United States: The Role of Race, Illicit Drug Use, and Income (full–2014)  https://www.researchgate.net/publication/265213487_Paranoid_Personality_Disorder_in_the_United_States_The_Role_of_Race_Illic%09it_Drug_Use_and_Income
Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332795/
Smoking synthetic marijuana leads to self-mutilation requiring bilateral amputations (full–2014) (Warning–graphic photos!) http://www.healio.com/orthopedics/journals/ortho/2014-4-37-4/%7Be1c1de76-8467-4810-8e5f-8f18bde50169%7D/smoking-synthetic-marijuana-leads-to-self-mutilation-requiring-bilateral-amputations
Risk-taking in schizophrenia and controls with and without cannabis dependence (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308438/
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (full–2014)  http://www.nature.com/npp/journal/v40/n6/full/npp2014329a.html
Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia  with and without Concurrent Cannabis Use (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988552/
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on  facial emotion recognition: A randomised, double-blind, placebo-controlled study in
cannabis users (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398332/
Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress  Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other
Indications: A Retrospective Evaluation (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165471/
Cannabis use and suicidal ideations in high-school students (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
Cannabis Use and its Effects on Health, Education and Labor Market Success (link to PDF-2014) http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2414469
Could spice drugs induce psychosis with abnormal movements similar to catatonia? (1st page–2014) http://guilfordjournals.com/doi/abs/10.1521/psyc.2014.77.2.206
Cannabis use and suicidal ideations in high-school students (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25123343
Cannabinoids and schizophrenia: therapeutic prospects (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/23829368
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst–2014) http://www.sciencedirect.com/science/article/pii/S0278584614000840+
Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24853061
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25138234
Cannabinoids reward sensitivity in a neurodevelopmental animal model of schizophrenia: A brain stimulation reward study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25092427
Use of Synthetic Cannabinoids in Patients With Psychotic Disorders: Case Series (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25392292
The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydro-cannabinol (abst–2014) http://www.psy-journal.com/article/S0165-1781(14)00831-2/fulltext
top

Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24776491
An Introduction to the Endogenous Cannabinoid System (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789136/
Impact of Cannabis Use on the Development of Psychotic Disorders (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352721/
Synthetic cannabis-induced mania (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369931/
Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice (abst–2015) http://ijnp.oxfordjournals.org/content/18/5/pyu041.long
Cannabis and psychopathology: The meandering journey of the last decade (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462782/
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640353/
A clinical comparison of schizophrenia with and without pre-onset cannabis use disorder: a retrospective cohort study using categorical and dimensional approaches (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676097/
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586320/
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640936/
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia (full–2015) http://neuro.psychiatryonline.org/doi/full/10.1176/appi.neuropsych.12120398
Further human evidence for striatal dopamine release induced by administration of Δ9- tetrahydrocannabinol (THC): selectivity to limbic striatum (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816196/
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537180/
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604232/
The phytocannabinoid, Δ(9) -tetrahydrocannabivarin, can act through 5-HT1 A receptors to produce antipsychotic effects (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337703/
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling (full–2015) http://www.cell.com/cell/fulltext/S0092-8674(15)00826-0
Molecular Targets of Cannabidiol in Neurological Disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604182/
Reduced Brain Cannabinoid Receptor Availability In Schizophrenia (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884543/
Genetic moderation of the effects of cannabis: catechol-O-methyltransferase (COMT)
affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance
but not on the occurrence of psychotic experiences (link to download–2015)  http://journals.sagepub.com/doi/full/10.1177/0269881115609073
Cannabis conundrum : Evidence of harm? : Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Marijuana, Reconsidered: Dr. Lester Grinspoon On 45 Years Of Cannabis Science (interview-2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lestergrinspoon/
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like  effects (abst-2015) https://www.ncbi.nlm.nih.gov/pubmed/25586398
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25680767
A systematic review of the antipsychotic properties of cannabidiol in humans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25667194
For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461500055X
Association of single nucleotide polymorphisms in catechol-O-methyltransferase and serine-threonine protein kinase genes in the Pakistani schizophrenic population: a study with special emphasis on cannabis and smokeless tobacco (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801838
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25943166
Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms (abst–2015) http://www.psyn-journal.com/article/S0925-4927(15)00112-2/fulltext
Catatonia and Cannabis Withdrawal: a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247767
No additive effect of cannabis on cognition in schizophrenia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26235754
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26370602
Endocannabinoids and Mental Disorders (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_8
The CCDC55 couples cannabinoid receptor CNR1 to a putative DISC1 schizophrenia pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26475744
Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis (abst–2015) http://www.psy-journal.com/article/S0165-1781%2815%2930166-9/abstract
Deletion of CB2 cannabinoid receptors reduces synaptic transmission and long-term potentiation in the mouse hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26663094
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26681496
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia:  Possible involvement of the endocannabinoid system (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26706691
Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological
interventions to treat and prevent psychosis (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26350340
top
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory (full–2016) http://www.hindawi.com/journals/np/2016/9817089/
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers (full–2016) http://www.nature.com/tp/journal/v6/n2/full/tp2015219a.html
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice (full–2016) https://peerj.com/articles/2081/
Synthetic Cannabinoid Receptor Agonist-Associated Psychotic Disorder: A Case Report (full-2016) http://www.turkpsikiyatri.com/en/default.aspx?modul=article&id=1020
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=10095&path%5B%5D=31745
First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone (full–2016) http://www.hindawi.com/journals/crips/2016/7257489/
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0158779
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial (full–2016) http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-016-1507-x
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0160949
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00303/full
Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature (full–2016) https://www.hindawi.com/journals/crips/2016/3640549/
Assessing causality in associations between cannabis use and schizophrenia risk: a twosample Mendelian randomization study (full–2016) https://www.cambridge.org/core/journals/psychological-medicine/article/div-classtitleassessing-causalityin-associations-between-cannabis-use-and-schizophrenia-risk-a-two-sample-mendelian-randomizationstudydiv/122D651C3670683DAEDDA33997417105/core-reader
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854973/
Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients (full–2016) https://www.dovepress.com/clinical-characteristics-of-synthetic-cannabinoid-induced-psychosis-in-peerreviewed-fulltext-article-NDT
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273(16)30509-8
Salience attribution and its relationship to cannabis-induced psychotic symptoms (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122315/
Lipids in psychiatric disorders and preventive medicine (full–2016)  http://www.sciencedirect.com/science/article/pii/S0149763415303353
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis  Use (full–2016) https://academic.oup.com/schizophreniabulletin/article-lookup/doi/10.1093/schbul/sbw030
The endocannabinoid system and NGF are involved in the mechanism of action of  resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric
disorders (full–2016) http://link.springer.com/article/10.1007/s00213-015-4188-3
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit (click “Full Text Links” for PDF–2016) http://www.ncbi.nlm.nih.gov/pubmed/26875559
Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients (click “full text links” for download–2016) https://www.ncbi.nlm.nih.gov/pubmed/28492376
Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in  Schizophrenia (1st page–2016)  http://www.biologicalpsychiatryjournal.com/article/S0006-3223%2816%2932303-4/abstract
Suppressing Schizophrenia Symptoms Without Side Effects: Mouse Study (news & abst–2016) http://neurosciencenews.com/schizophrenia-compound-striatum-5089/
A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in
Individuals with Schizophrenia or Schizoaffective Disorder (abst–2016)  http://link.springer.com/article/10.1007/s11126-016-9426-2/fulltext.html
Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis (abst–2016) http://journals.sagepub.com/doi/full/10.1177/0269881116658990
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive  deficits in first-episode psychosis (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26783729
Violence and self-harm in severe mental illness: inpatient study of associations with  ethnicity, cannabis and alcohol (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27679634
Cannabis and Psychosis: a Critical Overview of the Relationship (abst–2016)  http://link.springer.com/article/10.1007/s11920-015-0657-y
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia (abst–2016) http://link.springer.com/article/10.1007/s12035-016-9697-5
A Case of Butane Hash Oil (Marijuana Wax)-Induced Psychosis (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26820171
Cannabinoids for the Treatment of Schizophrenia: An Overview (abst–2016)  http://www.eurekaselect.com/139245/article
COMT Val158Met genotype and cannabis use in people with an At Risk Mental State for  psychosis: Exploring Gene x Environment interactions (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27052366
Cannabis-induced psychosis associated with high potency “wax dabs” (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26876313
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1043661816000396
Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26970364 Metabolic syndrome in people with a psychotic illness: is cannabis protective? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965714
Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26987678
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26903256
Acute Psychosis after Consumption of Synthetic Cannabinoids (abst in German & English–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0042-103425
Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597 (abst–2016) http://www.sciencedirect.com/science/article/pii/S0168010216300220
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27149691
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415302943
Could cannabidiol be used as an alternative to antipsychotics? (abst–2016) http://www.journalofpsychiatricresearch.com/article/S0022-3956(16)30104-2/abstract
Cannabis and Alcohol Use, Affect, and Impulsivity in Psychiatric Outpatients’ Daily Lives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27270874
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia (abst 016) http://www.schres-journal.com/article/S0920-9964(16)30060-3/abstract
Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27379411
Does cannabidiol have a role in the treatment of schizophrenia? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27374322
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616301269
Cannabis and a lower BMI in psychosis: What is the role of AKT1? (abst–2016) http://www.schres-journal.com/article/S0920-9964(16)30364-4/abstract
Cannabinoids and Psychosis (3) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568729
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia (abst–2016) http://www.psy-journal.com/article/S0165-1781(16)30347-X/fulltext
Abnormal white matter integrity in synthetic cannabinoid users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27617779
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303638
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016306930
Cannabinoids: Glutamatergic Transmission and Kynurenines (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27651254
Drug Dependence and Toxicity of Law-Evading Drugs: Their Mechanisms Explored from Basic Research (abst in English–2016) https://www.ncbi.nlm.nih.gov/pubmed/27703102  (abst in Japanese) http://medicalfinder.jp/doi/abs/10.11477/mf.1416200568
Association of Anandamide with altered Binocular Depth Inversion Illusion in Schizophrenia (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27734750
Characteristics associated with synthetic cannabinoid use among patients treated in a public psychiatric emergency setting (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797288
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) http://www.eurekaselect.com/146891/article
Targeting the Endocannabinoid System in Psychiatric Illness (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27811555
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence (abst–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00422/full
The effects of cannabis use on salience attribution: a systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27866486
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
The consequences of chronic cannabis smoking in vulnerable adolescents (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27986504
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27964871
The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice (full–2017) http://link.springer.com/article/10.1007%2Fs12640-017-9702-4
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of  Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508788/
Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514308/
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
New drugs in psychiatry: focus on new pharmacological targets (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373420/
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569624/
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and  Directions for Basic Research (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478733/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders (full–2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447368/
Schizophrenia and depression, two poles of endocannabinoid system deregulation (full–2017) https://www.nature.com/articles/s41398-017-0029-y
Cannabinoid Modulation of the Stressed Hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742214/
To Dab or Not to Dab: Rising Concerns Regarding the Toxicity of Cannabis Concentrates (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679763/
Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698868/
Short communication: Genetic association between schizophrenia and cannabis use  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28086176
A preliminary study of endocannabinoid system regulation in psychosis: Distinct  alterations of CNR1 promoter DNA methylation in patients with schizophrenia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28108228
Cannabis use, COMT, BDNF and age at first-episode psychosis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28142064
Clinical Characteristics of Synthetic Cannabinoid Use in a Large Urban Psychiatric  Emergency Setting (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/10826084.2016.1263663?journalCode=isum20
Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system:  Implications for novel schizophrenia treatments (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0149763416307102
Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28190094
Associations between substance use disorders and suicide or suicide attempts in people  with mental illness: A Danish nationwide, prospective, register-based study of patients  diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality  disorder (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28192643
The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein  Predicts Cannabinoid-Antipsychotic Drug Interactions (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28272498
Improved Social Interaction, Recognition and Working Memory with Cannabidiol  Treatment in a Prenatal Infection (poly I:C) Rat Model (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28230072
Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28242263
Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent  schizophrenia patients versus non-psychiatric controls (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28285022
HDAC1 and HDAC3 Underlie Dynamic H3K9 Acetylation During Embryonic Neurogenesis and in Schizophrenia-like Animals (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28300292
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia:  Evidence for defective immunomodulatory mechanisms (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0022395616307373
Metabolic side effects induced by olanzapine treatment are neutralized by CB1 receptor  antagonist compounds co-administration in female rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28377074
The impact of current cannabis use on general cognitive function in people with  psychotic illness (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28381332
Cannabinoids as hippocampal network administrators (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301405?via%3Dihub
Synthetic Cannabinoids: psychopharmacology, clinical aspects, and psychotic onset  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28412921
JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception  Disorder Five-Year Follow-Up (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28441106
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent  Patients with Schizophrenia versus Non-Psychiatric Controls (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28443616
Characteristics of socially withdrawn youth in France: A retrospective study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28446040
Synthetic cannabinoid use in an acute psychiatric inpatient unit (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28503792
Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis (abst–2017) http://www.psy-journal.com/article/S0165-1781(17)30055-0/fulltext
Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28544955
Voluntary exercise improves cognitive deficits in female dominant-negative DISC1  transgenic mouse model of neuropsychiatric disorders (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/15622975.2017.1323118?journalCode=iwbp20
The relationship between cannabis use and cortisol levels in youth at ultra high-risk for  psychosis (abst–2017) http://www.psyneuen-journal.com/article/S0306-4530(17)30113-0/fulltext
Oral haloperidol or olanzapine intake produces distinct and region-specific increase in  cannabinoid receptor levels that is prevented by high fat diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28619471
The association of cannabis use on inpatient psychiatric hospital outcomes (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28613973
Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to  phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice (abst–2017) http://www.sciencedirect.com/science/article/pii/S0091305717301211
At the intersection of neurology and psychiatry : the impact of the differential diagnosis  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653514
Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat  model of schizophrenia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28704273
DSM-5 cannabis use disorder in the National Epidemiologic Survey on Alcohol and  Related Conditions-III: Gender-specific profiles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28755613
Synthetic Cannabis Analogues and Suicidal Behavior: Case Report (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28796120
Understanding marijuana’s effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot
investigation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28823723
Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study (abst–2017) https://www.karger.com/Article/Abstract/479554
Is there a role for cannabidiol in psychiatry? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28112021
Death by self-mutilation after oral cannabis consumption (abst–2017)  http://www.legalmedicinejournal.com/article/S1344-6223(17)30258-4/fulltext
Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4766-7
Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic  deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids
imbalance (abst–2017)  http://www.jneurosci.org/content/early/2017/06/20/JNEUROSCI.3516-16.2017
Motivational changes of cannabis use prior to and during the course of schizophrenia  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28004866
THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell Derived
Neurons (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29230395
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter  Randomized Controlled Trial (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29241357
Cannabis induced psychosis and subsequent psychiatric disorders (abst–2017)  http://www.asianjournalofpsychiatry.com/article/S1876-2018(17)30388-X/fulltext
The effect of interactions between genetics and cannabis use on neurocognition. A  review (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0278584617304785?via%3Dihub
Perspectives of cannabis use in the life experience of men with schizophrenia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29218823
From “Azalla” to Anandamide: Distilling the Therapeutic Potential of Cannabinoids (full–2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752109/
Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and  bipolar disorder patients with cannabis use (full–2018)  http://www.europeanneuropsychopharmacology.com/article/S0924-977X(17)32024-2/fulltext
Adolescent synthetic cannabinoid exposure produces enduring changes in dopamine  neuron activity in a rodent model of schizophrenia susceptibility (link to PDF–2018)
https://academic.oup.com/ijnp/advance-article/doi/10.1093/ijnp/pyy003/4796858
Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder  versus schizophrenia, or other psychotic disorders (abst–2018) http://www.psy-journal.com/article/S0165-1781(17)31110-1/fulltext
The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29083450
Differential approaches to the treatment of acute psychosis due to the use of synthetic  cannabinoids (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29376979
Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients  experiencing first episode psychosis: Data from the national RAISE-ETP study (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29356438
Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on  mouse corticostriatal circuitries: Implications for neuropsychiatric disorders (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29388323
Cannabinoids and glial cells: possible mechanism to understand schizophrenia (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29392440
Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine,  serotonin, and glutamate systems (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29385930


SCLERODERMA +
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893662/
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis (full–2010) http://onlinelibrary.wiley.com/doi/10.1002/art.27642/full
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21177293
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22492781
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22033526
Pathogenesis of Systemic Sclerosis (full–2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757881/
Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis? (link to PDF–2016) http://www.ima.org.il/imaj/ViewArticle.aspx?aId=3850
Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
Cannabinoids, inflammation, and fibrosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27435265
top


SEBACEOUS GLANDS +
Expression of cannabinoid receptor I during mice skin incised wound healing course
(abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20967946
“Sebocytes’ makeup”: novel mechanisms and concepts in the physiology of the human sebaceous glands (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21384129
Cannabinoid receptor type 2 is time-dependently expressed during skin wound healing in mice (abst-2012) https://link.springer.com/article/10.1007%2Fs00414-012-0741-3
TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240254/
Cannabidiol exerts sebostatic and anti-inflammatory effects on human sebocytes (full–2014) http://www.jci.org/articles/view/64628
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26142529
Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrheic skin and acne treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27094344
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (full–2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext


SEBORRHEA
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (full–2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext


SEPTIC SHOCK/SEPSIS/ENDOTOXEMIA*+
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20561509
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
The endocannabinoid system in sepsis – a potential target to improve microcirculation? (full–2011) http://www.signavitae.com/articles/review-articles/161-the-endocannabinoid-system-in-sepsis-a-potential-target-to-improve-microcirculation
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21279327
Cannabinoids and sepsis (abst–2011) http://www.trendsanaesthesiacriticalcare.com/article/S2210-8440%2811%2900049-9/fulltext
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related  systemic inflammation (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21551239
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis (full–2012) http://ccforum.com/content/16/2/R47
Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis (full–2012) http://journals.lww.com/anesthesia-analgesia/Fulltext/2012/06000/Cannabinoid_Receptor_1_Inhibition_Causes_Seizures.12.aspx
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012)
http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice (full–2013) http://www.hindawi.com/journals/mi/2013/741303/
Cytokine release in sepsis (full–2013) http://file.scirp.org/Html/36257.html
Targeting the Endocannabinoid System to Treat Sepsis (review–2013) http://www.signavitae.com/articles/review-articles/222-targeting-the-endocannabinoid-system-to-treat-sepsis
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23382309
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full–2014) http://www.hindawi.com/journals/mi/2014/978678/
top
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080545/
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells  (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036321/
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full–2014) http://www.hindawi.com/journals/mi/2014/978678/
Novel approaches to the development of anti-sepsis drugs (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24697209
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/100/6/F541
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376457/
Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26410875
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full Involvement of Central Endothelin ETA and Cannabinoid CB1 Receptors and Arginine Vasopressin Release in Sepsis Induced by Cecal Ligation and Puncture in Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26925810
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator  constitutively secreted by adrenals and in liver upon tissue damage (full–2017)  https://www.nature.com/articles/s41598-017-09808-8
N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via  Nonhematopoietic TRPV1 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544930/
Immunoregulatory Role of Cannabinoids during Infectious Disease (full–2017)  https://www.karger.com/Article/FullText/481824
Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic  Shock (full–2017) http://www.mdpi.com/2218-1989/7/4/55/htm
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions,  Possibilities, and Challenges (full-2017)  https://www.frontiersin.org/articles/10.3389/fimmu.2017.01487/full
Cannabinoids in the Cardiovascular System (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1054358917300431?via%3Dihub
Cannabinoid Receptor 2 Modulates Neutrophil Recruitment in a Murine Model of  Endotoxemia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28852269
An endocannabinoid uptake inhibitor from black pepper exerts pronounced antiinflammatory effects in mice (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jafc.7b02979
Betacaryophyllene – A phytocannabinoid as potential therapeutic modality for human  sepsis? (full–2018) http://www.medical-hypotheses.com/article/S0306-9877(17)30861-7/fulltext


SEXUAL ABUSE
Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent  Behavioral Deficits That Can Be Improved by Neurosteroid-Based Treatment (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581875/
Demographic and clinical characteristics of treatment seeking women with full and  subthreshold PTSD and concurrent cannabis and cocaine use disorders (abst–2017) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(17)30009-0/fulltext
Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders: variation by race/ethnicity? (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29310741


SICKLE CELL DISEASE +
New Era Dawns on Sickle Cell Pain (full–2010) http://bloodjournal.hematologylibrary.org/cgi/reprint/116/3/311
Pain related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids (full–2010) http://bloodjournal.hematologylibrary.org/content/116/3/456.long
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779783/
Traditional Herbal Management of Sickle Cell Anemia: Lessons from Nigeria (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502758/
Priapism in a patient with sickle cell trait using marijuana (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025395/
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation (link to PDF–2015) http://www.haematologica.org/content/early/2015/12/21/haematol.2015.136523.long
The Use of Marijuana and Hydroxyurea Among Sickle Cell Patients (full–2015)  http://www.bloodjournal.org/content/128/22/5913?sso-checked=true
Quantification of pain in sickle mice using facial expressions and body measurements (abst–2016) http://www.sciencedirect.com/science/article/pii/S1079979615300218
Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26956672
The Use of Cannabis by Patients with Sickle Cell Disease Increased the Frequency of
Hospitalization due to Vaso-Occlusive Crises (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627667/
Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local  inhibition of anandamide hydrolysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28570479


SKIN
Electroacupuncture increases CB2 receptor expression on keratinocytes and infiltrating  inflammatory cells in inflamed skin tissues of rats (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20627823
Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic  effects in skin (abst–2010)  http://www.sciencedirect.com/science/article/pii/S0006295210001577
Expression of cannabinoid receptor I during mice skin incised wound healing course  (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20967946 
Image of the month. Skin discoloration from compulsive bathing in a patient with  hyperemesis syndrome (full–2011)  http://www.cghjournal.org/article/S1542-3565%2810%2900843-8/fulltext
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin  Tissues by Electroacupuncture (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in  Cnr1(-/-) mice (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/20724033
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed  skin tissues through activation of cannabinoid CB2 receptors (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22337285
Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs. spinally-innervated skin (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394407/
Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell  behavior in a canine model of allergic dermatitis (full–2012)  http://www.biomedcentral.com/1746-6148/8/230
Endocannabinoids limit excessive mast cell maturation and activation in human skin  (full–2012) http://www.jacionline.org/article/S0091-6749%2811%2901796-9/fulltext
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with  atopic dermatitis (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22738050
Cannabinoid receptor type 2 is time-dependently expressed during skin wound healing  in mice (abst–2012) https://link.springer.com/article/10.1007%2Fs00414-012-0741-3
Epigenetic Control of Skin Differentiation Genes by Phytocannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996/
TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation  (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240254/
Detecting Cannabis Use on the Human Skin Surface via an Electronic Nose System (full–2014) http://www.mdpi.com/1424-8220/14/7/13256/htm
Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases? (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24823963
Lipid mediator profile in vernix caseosa reflects skin barrier development (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629127/
Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays  skin graft rejection through activation of cannabinoid receptor 1 and induction of  myeloid-derived suppressor cells (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541500/
Flax Fiber Hydrophobic Extract Inhibits Human Skin Cells Inflammation and Causes  Remodeling of Extracellular Matrix and Wound Closure Activation (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539444/
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human  cheek skin sebum and erythema content (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26142529
Cannabinoid CB2 receptors are involved in the regulation of fibrogenesis during skin  wound repair in mice (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805070/
Differential effectiveness of selected non-psychotropic phytocannabinoids on human  sebocyte functions implicates their introduction in dry/seborrheic skin and acne  treatment (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27094344
Pharmacological activation of cannabinoid 2 receptor attenuates inflammation,  fibrogenesis, and promotes re-epithelialization during skin wound healing (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27268717
Mustard vesicants alter expression of the endocannabinoid system in mouse skin (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X16300898
Comparison of protective effect of ascorbic acid on redox and endocannabinoid systems  interactions in in vitro cultured human skin fibroblasts exposed to UV radiation and  hydrogen peroxide (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387039/
Lipid functions in skin: Differential effects of n-3 polyunsaturated fatty acids on  cutaneous ceramides, in a human skin organ culture model (full–2017)  http://www.sciencedirect.com/science/article/pii/S0005273617300986
The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin  Inflammation in Mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28214870
Fatty acids and related lipid mediators in the regulation of cutaneous inflammation  (abst-2018) https://www.ncbi.nlm.nih.gov/pubmed/29330355


SLEEP APNEA+
Circulating endocannainoids and N-acyl-ethanolamides in patients with sleep apnea – specific role of oleoylethanolamide (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20429051
A study on the endogenous cannabinoid system synthetic and catabolic enzyme levels in patients with obstructive sleep apnea (abst in English–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21729625 (abst in Chinese) http://zhjhhhxzz.yiigle.com/CN112147201105/857124.htm?locale=zh_CN
Circulating anandamide and blood pressure in patients with obstructive sleep apnea (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23032139
Proof of concept trial of dronabinol in obstructive sleep apnea (full–2013) http://www.frontiersin.org/Sleep_Disorders/10.3389/fpsyt.2013.00001/full
Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880550/
top

Cardiorespiratory control as a function of wake-sleep behavior and diet in mice lacking  CB1 cannabinoid receptors (abst–2013)  http://www.fasebj.org/content/27/1_Supplement/926.1.short
Identification of a Pharmacological Target for Genioglossus Reactivation throughout Sleep (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902869/
Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869068/
Cannabinoid Type 1 and Type 2 Receptor Antagonists Prevent Attenuation of Serotonin Induced Reflex Apneas by Dronabinol in Sprague-Dawley Rats (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0111412
Cannabinoid Type 1 Receptor Antagonist, AM251, Prevents Attenuation Of Serotonin induced Apneas By Dronabinol In Sprague-Dawley Rats (abst–2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3901
Emerging Drugs for Common Conditions of Sleepiness: Obstructive Sleep Apnea and Narcolepsy (full–2015) http://www.tandfonline.com/doi/full/10.1517/14728214.2015.1115480
Circulating Endocannabinoids and Insulin Resistance in Patients with Obstructive Sleep Apnea (full–2016) http://www.hindawi.com/journals/bmri/2016/9782031/
Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats (full–2016) http://jnrbm.biomedcentral.com/articles/10.1186/s12952-016-0052-1
Cannabinoids as therapeutic for PTSD (abst–2017)  http://www.sciencedirect.com/science/article/pii/S2352250X16302342
Cannabis, Cannabinoids, and Sleep: a Review of the Literature (abst–2017)  http://link.springer.com/article/10.1007%2Fs11920-017-0775-9
Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague Dawley Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28934522
Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial:  Effects of Dronabinol in Obstructive Sleep Apnea (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29121334
Role of the endogenous cannabinoid receptor 1 in brain injury induced by chronic  intermittent hypoxia in rats (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29264962


SLEEPING SICKNESS/TRYPANOSOMIASIS*
Trypanocidal Effect of Cannabis sativa on Experimental Camel Trypansomosis (full–2012) http://scialert.net/fulltext/?doi=rjmp.2012.281.285&org=10


SLEEP MODULATION*+
Mixed mood disorder (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/228/?pagenum=2
Marijuana helps narcolepsy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/598/?pagenum=2
Achalasia, status post myotomy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/597/?pagenum=2
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?tool=pubmed
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial (full-2010) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2010/02000/The_Effects_of_Nabilone_on_Sleep_in_Fibromyalgia_.56.aspx
Endocannabinoid signalling: has it got rhythm? (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931554/
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant  for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Sleep and Medicinal Cannabis (abst-2010) http://www.cmcr.ucsd.edu/index.php?option=com_content&view=article&id=151:sleep-and-medicinalcannabis&catid=41:research-studies&Itemid=135
Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation (abst–2010)  http://www.sciencedirect.com/science/article/pii/S1043661810000241
Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20056119
An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or  Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral  Neuropathy (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=311
Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea-
specific role of oleoylethanolamide (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20429051
Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136458/?tool=pubmed
A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats (full–2011) http://www.hindawi.com/journals/sd/2011/178469/
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full–2011)  https://academic.oup.com/annonc/article/22/9/2086/211788/Delta-9-tetrahydrocannabinol-may-palliate-altered
top
Characterizing smoking topography of cannabis in heavy users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641906/
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Neuropsychiatric adverse effects of centrally acting antiobesity drugs (1st page–2011)
https://www.deepdyve.com/lp/wiley/neuropsychiatric-adverse-effects-of-centrally-acting-antiobesity-drugs-Sy0a9pYcBp
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats (abst–2011) http://www.sciencedirect.com/science/article/pii/S0028390811003467
Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21262236
The emerging role of the endocannabinoid system in the sleep-wake cycle modulation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21919868
CADTH Rapid Response Report: Cannabinoids for the treatment of post-traumatic stress disorder (full–2012) http://www.cadth.ca/media/pdf/htis/july-2012/RC0368%20Cannabinoids%20Final.pdf
Cannabidiol in humans-the quest for therapeutic targets (full–2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763649/
Neuromodulators for pain management in rheumatoid arthritis (abst/summary–2012)  http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008921.pub2/abstract
Oleamide restores sleep in adult rats that were subjected to maternal separation (abst–2012) http://www.sciencedirect.com/science/article/pii/S0091305712002493
An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22921260
Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical  and neurobiological evidence (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22736575
Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929256/
Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537525/
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23343597
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats (abst–2013)  http://www.sciencedirect.com/science/article/pii/S009130571300097X
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats (abst–2013) http://www.sciencedirect.com/science/article/pii/S0091305713001007
Cardiorespiratory control as a function of wake-sleep behavior and diet in mice lacking CB1 cannabinoid receptors (abst–2013) http://www.fasebj.org/content/27/1_Supplement/926.1.short
The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23238438
Sleep Quality Moderates the Relation between Depression Symptoms and Problematic Cannabis Use among Medical Cannabis Users (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23721537
The impact of perceived sleep quality and sleep efficiency/duration on cannabis use during a self-guided quit attempt (abst–2013) http://www.sciencedirect.com/science/article/pii/S030646031300172X
Poor sleep quality as a risk factor for lapse following a cannabis quit attempt (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23098380
Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under
challenging conditions in mice (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24037493
Endocannabinoid Modulation of Cortical Up-States and NREM Sleep (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919802/
top
Multiple sleep alterations in mice lacking cannabinoid type 1 receptors (full-2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0089432
Impact of dronabinol on quantitative electroencephalogram (qEEG) measures of sleep in obstructive sleep apnea syndrome (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869068/
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100536
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications: A Retrospective Evaluation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165471/
Potential effects of cannabidiol as a wake-promoting agent (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023456/
Urine Toxicology Screen in Multiple Sleep Latency Test: The Correlation of Positive
Tetrahydrocannabinol, Drug Negative Patients, and Narcolepsy (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298782/
When time stands still: an integrative review on the role of chronodisruption in  post traumatic stress disorder (full–2014) https://escholarship.org/uc/item/26d306vj
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24420962
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25504799
Anandamide activation of CB1 receptors increases spontaneous bursting and oscillatory activity in the thalamus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508153
Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats (abst–2014) http://www.sciencedirect.com/science/article/pii/S0168010214000716
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24845114
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0304394014005229
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes (abst–2014) http://link.springer.com/article/10.1007%2Fs00429-014-0842-5
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of  medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult  rats subjected to maternal separation (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25356522
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS (abst–2014)
http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of  Parkinson Disease: An Open-Label Observational Study (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24614667
Preliminary, open-label, pilot study of add-on oral δ(9)-tetrahydrocannabinol in chronic  post-traumatic stress disorder (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24935052
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331066/
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (full–2015) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900413-2/fulltext
top

Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care,
and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup  (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015)  http://jama.jamanetwork.com/article.aspx?articleid=2338251
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-arachidonoylglycerol (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763355/
Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A
systematic review of randomized controlled trials (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/acr.22727/full
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by  Parkinson’s Disease Patients in Colorado (full–2015)  http://www.hindawi.com/journals/ecam/2015/874849/
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the  modulation of distinct panic-like responses (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/25601395
The effects of chronic marijuana use on circadian entrainment (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25801606
Cannabis withdrawal and sleep: A systematic review of human studies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25893849
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/ojn89dh
Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26151582
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Rhythmic control of endocannabinoids in the rat pineal gland (abst–2015) http://informahealthcare.com/doi/abs/10.3109/07420528.2015.1041596
Endocannabinoid Signaling Regulates Sleep Stability (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152473
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (full–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30715-6/fulltext
The impact of drugs for multiple sclerosis on sleep (full–2016) http://journals.sagepub.com/doi/full/10.1177/1352458516664034
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165161/
Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a
comprehensive review (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845302/
Dose-dependent cannabis use, depressive symptoms, and FAAH genotype predict sleep  quality in emerging adults: a pilot study (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289074/
Importance of Urinary Drug Screening in the Multiple Sleep Latency Test and  Maintenance of Wakefulness Test (full–2016)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155193/
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on  Executive Function (full–2016)  http://journal.frontiersin.org/article/10.3389/fphar.2016.00355/full
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26757043
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice (abst–2016) https://link.springer.com/article/10.1007%2Fs00429-016-1214-0
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27160412
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Disturbances of sleep and circadian rhythms: novel risk factors for obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27584008
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27659736
Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27746343
Endocannabinoids and sleep (abst-2016) http://www.sciencedirect.com/science/article/pii/S0149763416302640
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30171-7/fulltext
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of  THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016)  https://www.karger.com/Article/Abstract/445943
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Recent legalization of cannabis use: effects on sleep, health, and workplace safety (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5656354/
Clinical Evidence for Utilizing Cannabinoids in the Elderly (link to PDF–2017)  https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
The endocannabinoid system modulating levels of consciousness, emotions and likely  dream contents (abst–2017) http://www.eurekaselect.com/150392/article
Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A  literature review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28245077
Prevalence of teenage sleeping disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28242150
Cannabinoids as therapeutic for PTSD (abst–2017)  http://www.sciencedirect.com/science/article/pii/S2352250X16302342
Cannabis, Cannabinoids, and Sleep: a Review of the Literature (abst–2017)  http://link.springer.com/article/10.1007%2Fs11920-017-0775-9
Anandamide and 2-AG Are Endogenously Present within the Laterodorsal Tegmental  Nucleus: Functional Implications for a role of eCBs in arousal (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28404451
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28372506
Effects of sleep on substance use in adolescents: a longitudinal perspective (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28547821
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28653665
Daily associations between cannabis motives and consumption in emerging adults (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30278-8/fulltext
The excitatory/inhibitory input to orexin/hypocretin neuron soma undergoes day/night
reorganization (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28669028
Smoked marijuana attenuates performance and mood disruptions during simulated night shift work (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30309-5/fulltext
Drowsiness and uncommon fever in a child after cannabis ingestion (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28751294
Sleep continuity, architecture and quality among treatment-seeking cannabis users: An
in-home, unattended polysomnographic study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28782982
Effects of Cannabinoid Agonists and Antagonists on Sleep and Breathing in Sprague Dawley Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28934522
Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28537982
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in
dementia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29256923
Peripheral Endocannabinoids Associated with Energy Expenditure in Native Americans
of Southwestern Heritage (abst–2017) https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/jc.2017-02257/4780813?redirectedFrom=fulltext
Efficacy and safety of cannabis for treating children with refractory epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29115760
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep  (abst–2017) http://journals.sagepub.com/doi/abs/10.1177/0269881117699616
The therapeutic effects of Cannabis and cannabinoids: An update from the National  Academies of Sciences, Engineering and Medicine report (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29325791


SMALLPOX +
Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21131094/abstract/Cannabinoids_lead_to_enhanced_virulence_of_the_smallpox_vaccine__vaccinia__virus_
Genome-wide association study of antibody response to smallpox vaccine (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367131/
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full–2015) http://www.hindawi.com/journals/mi/2015/349176/

top


SMELL/ODOR DETECTION +
The endocannabinoid 2-arachidonoyl-glycerol controls odor sensitivity in larvae of Xenopus laevis (full–2010) http://www.jneurosci.org/content/30/26/8965.long
Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20875432
Endocannabinoid modulation in the olfactory epithelium (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20865377
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full–2011) https://academic.oup.com/annonc/article/22/9/2086/211788
Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb: Involvement of Endocannabinoids-Cannabinoids and Acute Stress Modulate GABA Release (full–2011) http://www.hindawi.com/journals/ijcb/2011/529851/
Cannabinoid receptor-mediated regulation of neuronal activity in the main olfactory bulb (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397690/
Handler beliefs affect scent detection dog outcomes (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078300/
US Patent EP 2560512 A1-Smoke and Odor Elimination Filters, Devices and Methods (full–2011) http://www.google.com/patents/EP2560512A1?cl=en 

Disruptive effects of the prototypical cannabinoid Δ⁹-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21512341
Cannabinoid receptor-mediated regulation of neuronal activity and signaling in glomeruli of the main olfactory bulb (full– 2012) http://www.jneurosci.org/content/32/25/8475.long
G-Protein-Coupled Receptors in Intestinal Chemosensation (full–2012) http://www.sciencedirect.com/science/article/pii/S1550413112000198
Sniffing out pharmacology: interactions of drugs with human olfaction (abst–2012)  http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147(12)00016-8
Identification of odorant-receptor interactions by global mapping of the human odorome (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093037
Effects of 20 mg oral Δ9 -tetrahydrocannabinol on the olfactory function of healthy volunteers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243870/ 
Detecting Cannabis Use on the Human Skin Surface via an Electronic Nose System (full–2014) http://www.mdpi.com/1424-8220/14/7/13256/htm
The endocannabinoid system controls food intake via olfactory processes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24509429
New insights on food intake control by olfactory processes: the emerging role of the endocannabinoid system (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0303720714003037
Food intake regulation-2nd part (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24564775

Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons (full–2015) http://www.mdpi.com/1660-4601/13/1/5/htm
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485596/
Detection of Illicit Drugs by Trained Honeybees (Apis mellifera) (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471073/ 

A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26162535
A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148734
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit (click “Full Text Links” for PDF–2016) http://www.ncbi.nlm.nih.gov/pubmed/26875559
Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26996621
Effects of analgesics on olfactory function and the perception of intranasal trigeminal stimuli (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27320501
Cannabinoid receptor signaling induces proliferation but not neurogenesis in the mouse olfactory epithelium (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27606334
top
The role of the endocannabinoid system in the antihyperalgesic effect of Cedrus atlantica essential oil inhalation in a mouse model of postoperative pain (full–2017)  http://www.sciencedirect.com/science/article/pii/S0378874117320172?via%3Dihub 

Effects of oral Δ9-tetrahydrocannabinol on the cerebral processing of olfactory input in  healthy non-addicted subjects (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28866743 
Evaluation of Cannabinoid and Terpenoid Content: Cannabis Flower Compared to  Supercritical CO2 Concentrate (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28926863 
LEARNING-INDUCED MODULATION OF THE EFFECT OF ENDOCANNABINOIDS ON INHIBITORY SYNAPTIC TRANSMISSION (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29167327


SMOKED CANNABIS AS A MEDICATION*+
Achalasia, status post myotomy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/597/?pagenum=2

Rectal spasms (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/791/
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?tool=pmcentrez
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study (full–2010)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/ 
Canadian Ophthalmological Society policy statement on the medical use of marijuana for glaucoma (article-2010) http://www.canadianjournalofophthalmology.ca/article/S0008-4182%2810%2980129-2/abstract
The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=309
Denial of hepatic transplantation on the basis of smoking: is it ethical? (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20154621 

Cannabis Use in Patients with Fibromyalgia: Effect on Symptoms Relief and Health-Related Quality of Life (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080871/?tool=pubmed 
Posttraumatic Stress and Marijuana Use Coping Motives: The Mediating Role of Distress  Tolerance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101637/
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas-possible role of Cannabis inhalation (full–2011) http://cannabisclinicians.org/wp-content/uploads/2011/12/Cannabis-Inhalation-and-Brain-TumorRegression-2011.pdf
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011)  http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Medical cannabis use in post-traumatic stress disorder: a naturalistic observational study (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=481
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial (full–2012) http://www.cmaj.ca/content/184/10/1143.long
Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/acr.21732/full
It can’t hurt to ask; a patient-centered quality of service assessment of health canada’s  medical cannabis policy and program (full–2012)  https://harmreductionjournal.biomedcentral.com/articles/10.1186/1477-7517-9-2
Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms (full–2012) https://escholarship.org/uc/item/49k8d6hq
Use of cannabis among 139 cluster headache sufferers (download–2012)  http://scholar.google.com/scholar_url?url=https://www.researchgate.net/profile/Elizabeth_Leroux/publication/278871004_Cluster_Headache_Cluster_Headache_and_Cannabis/links/563f912008ae45b5d28d30e8.pdf&hl=en&sa=X&scisig=AAGBfm2FeWNia7xmI9Y7qQcIo3XFnscxeA&nossl=1&oi=scholarr
Seizure exacerbation in two patients with focal epilepsy following marijuana cessation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23159379
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/25876933
Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study (abst–2012)  https://www.ncbi.nlm.nih.gov/pubmed/22095142 

A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men  (abst–2012)  http://www.unboundmedicine.com/medline/ebm/record/22133305/abstract/A_pilot_study_of_the_effects_of_cannabis_on_appetite_hormones_in_HIV_infected_adult_men_
The impact of marijuana use on glucose, insulin, and insulin resistance among US adults (full–2013) http://www.amjmed.com/article/S0002-9343%2813%2900200-3/fulltext
Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV-Hepatitis C Coinfection: A Longitudinal Cohort Analysis (full–2013) http://cid.oxfordjournals.org/content/early/2013/07/03/cid.cit378.long
Towards a better Cannabis drug (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12400/full
Cannabis and other illicit drug use in epilepsy patients (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/ene.12081/full
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005175.pub3/full
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120 (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476243/
top
Cannabis Induces a Clinical Response in Patients with Crohn’s Disease: a Prospective Placebo-Controlled Study (full–2013) http://www.cghjournal.org/article/S1542-3565%2813%2900604-6/fulltext
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana In Daily Marijuana Smokers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746706/
Medical Marijuana Coverage Still Lost in the Legal Weeds (article–2013) http://www.managedcaremag.com/linkout/2013/1/23
Medicinal Cannabis and Painful Sensory Neuropathy (editorial–2013) http://virtualmentor.ama-assn.org/2013/05/oped1-1305.html
Cannabis and other illicit drug use in epilepsy patients (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23311572 

Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24289844
Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23291209
Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations (full–2014) http://www.cfp.ca/content/60/12/1083.long
Endocannabinoids Control Platelet Activation and Limit Aggregate Formation under Flow (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0108282
Patterns and correlates of cannabis use among individuals with HIV/AIDS in Maritime Canada (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950986/
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170074/
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010 (abst–2014) http://www.drugandalcoholdependence.com/article/S0376-8716%2814%2901929-2/abstract?cc=y
Inhaled medicinal cannabis and the immunocompromised patient (full – 2014) MASSC
High-intensity cannabis use associated with lower plasma human immunodeficiency  virus-1 RNA viral load among recently infected people who use inject ion drugs (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363114/ 

Summary of evidence-based guideline: Complementary and alternative medicine in  multiple sclerosis (full–2014) http://www.neurology.org/content/82/12/1083.full 
How Smoking Marijuana Might Be The Best Way To Prevent Alzheimer’s Disease (interview–2014) http://www.leafscience.com/2014/01/30/smoking-marijuana-might-best-way-prevent-alzheimers-disease/
Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: An Open-Label Observational Study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24614667
Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25052875
Effect of Marijuana Use on Outcomes in Traumatic Brain Injury (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25264643 
Cannabis, cannabidiol, and epilepsy – From receptors to clinical response (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25282526
Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study (abst–2014)  http://www.drugandalcoholdependence.com/article/S0376-8716(14)01975-9/fulltext
The Association Between Normal Optic Nerve Cupping , Normal Visual Fields and Marijuana Use (abst–2014) http://iovs.arvojournals.org/article.aspx?articleid=2271290&resultClick=1
top
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541447/
Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH) (full–2015) http://cid.oxfordjournals.org/content/61/1/40.long
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519555/
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Self-medication of achalasia with cannabis, complicated by a cannabis use disorder (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i20/6381.htm
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia (full–2015) http://neuro.psychiatryonline.org/doi/full/10.1176/appi.neuropsych.12120398
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (full–2015) http://www.jpsmjournal.com/article/S0885-3924(14)00312-1/fulltext
Cannabis Smoking and Diabetes Mellitus: Results from Meta-analysis with Eight Independent Replication Samples (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801109/ 
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0367-5
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536087 
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666747/
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS) (full–2015) http://www.jpain.org/article/S1526-5900(15)00837-8/fulltext
Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men’s Health Study (full–2015) http://www.goldjournal.net/article/S0090-4295(14)01206-0/fulltext
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25950588

Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26364922
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716(15)01646-4/abstract
top
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Is cannabis use associated with less opioid use among people who inject drugs? (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900250-1/abstract
Use of medical cannabis to reduce pain and improve quality of life in cancer patients  (abst–2015) http://meetinglibrary.asco.org/content/155674-165

“I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156614
Joint Effects: A Pilot Investigation of the Impact of Bipolar Disorder and Marijuana Use on Cognitive Function and Mood (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157060
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Neuropathic Pain Treatment: Still a Challenge (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935814/
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic  Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869907/ 
Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adults (link via ELSEVIER to Full Text–2016) https://www.ncbi.nlm.nih.gov/pubmed/27889592
Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization? (link to PDF–2016) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4045 

The use of medical-grade cannabis in patients non-responders to Nabiximols (1st page–2016) http://www.jns-journal.com/article/S0022-510X(16)30472-5/abstract
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population  (abst–2016) http://onlinelibrary.wiley.com/doi/10.1002/phar.1673/full 

Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26820826
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies (abst in German & English) http://link.springer.com/article/10.1007%2Fs00482-015-0089-y
Plant-Derived and Endogenous Cannabinoids in Epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26892745
Cannabinoids: Medical implications (abst–2016) http://www.tandfonline.com/doi/abs/10.3109/07853890.2016.1145794?journalCode=iann20C
Cannabis in Pain Treatment: Clinical & Research Considerations (abst–2016)  http://www.jpain.org/article/S1526-5900(16)00543-5/fulltext
Metabolic syndrome in people with a psychotic illness: is cannabis protective? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965714
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26889611
No significant effect of cannabis use on the count and percentage of circulating CD4 Tcells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27073179
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27267445
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883 Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27579692
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst in German & English-2016) https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson’s disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27723182
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27763968
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842047
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017) https://www.ncbi.nlm.nih.gov/books/NBK65875/ 

Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176416
Cannabis and cognitive functioning in multiple sclerosis: The role of gender (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468765/
Is cannabis an effective treatment for joint pain? (link to PDF-2017)  http://www.clinexprheumatol.org/abstract.asp?a=12225
Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A  literature review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28245077 

Cannabis and Cannabinoids for Chronic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28983880


SOCIAL ADJUSTMENT/BEHAVIOR*+
Influence of cannabis use trajectories, grade repetition and family background on the school-dropout rate at the age of 17 years in France (full–2010) http://eurpub.oxfordjournals.org/content/20/2/157.long 
Uni-Morbid and Co-Occurring Marijuana and Tobacco Use: Examination of Concurrent Associations with Negative Mood States (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861285/?tool=pubmed
Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition (full–2010) http://molpharm.aspetjournals.org/content/78/2/260.long
A Life-course Perspective on the “Gateway Hypothesis” (link to download–2010)  https://www.researchgate.net/publication/47414508_A_Life-course_Perspective_on_the_Gateway_Hypothesis
Patterns of Youth Participation in Cannabis Cultivation (link to download–2010)  http://jod.sagepub.com/content/40/2/263.abstract 

A Sociological Theory of Drug Sales, Gifts, and Frauds (abst–2010)  http://journals.sagepub.com/doi/full/10.1177/0011128710386199 
Cannabis and crime: findings from a longitudinal study (abst–2010)  https://www.ncbi.nlm.nih.gov/pubmed/19839964 
Gender moderates the impact of stereotype threat on cognitive function in cannabis users (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20483199 
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19854030 
Sex difference in cell proliferation in developing rat amygdala mediated by endocannabinoids has implications for social behavior (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?tool=pubmed
Gender differences in adolescent marijuana use and associated psychosocial characteristics (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359836/
top

Drug-Intake Methods and Social Identity: The Use of Marijuana in Blunts Among Southeast Asian Adolescents and Emerging Adults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193281
Rural Adolescent Alcohol, Tobacco and Illicit Drug Use: A Comparison of Students in Victoria, Australia and Washington State, United States (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186916/
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/
The social contagion effect of marijuana use among adolescents (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018468/?tool=pubmed
Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258364/
The association between early conduct problems and early marijuana use in college students (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163297/
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and  cannabis regulation? (full–2011)  http://www.lufg.com.au/files/media/Popular_intoxicants_what_lessons_can_be_learned.pdf 

Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in  Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress (full–2011) http://cercor.oxfordjournals.org/content/21/9/2056.full 
Variation in the human Cannabinoid Receptor (CNR1) gene modulates gaze duration for  happy faces (full–2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155489/ 
Profile of Psychoactive Substances Consumption in Workplace (abst in French & English–2011) https://www.journal-therapie.org/articles/therapie/abs/2011/02/th111929/th111929.html 
Alcohol and cannabis abuse/dependence symptoms and life satisfaction in young adulthood (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21733007
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033260
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664416/
Cannabidiol in humans-the quest for therapeutic targets (full–2012)   https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763649/
Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389197/
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats (full–2012)  http://journals.sagepub.com/doi/full/10.1177/0269881112441865
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572464/ 

The combined effects of parental divorce and parental history of depression on cannabis use in young adults in France (link to PDF–2012) https://hal.archives-ouvertes.fr/inserm-00708161
Cannabis Use Vulnerability Among Socially Anxious Users: Cannabis Craving During a Social Interaction (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23002698
‘It’s just a social thing’: Drug use, friendship and borderwork among marginalized young people (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23352335
Cannabis-related impairment and social anxiety: the roles of gender and cannabis use motives (abst–2012) https://www.ncbi.nlm.nih.gov/pubmed/22766487

Predictors of stigmatization towards use of various illicit drugs among emerging adults (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23061324 
Marijuana-related problems and social anxiety: the role of marijuana behaviors in social situations (abst–2012) https://www.ncbi.nlm.nih.gov/pubmed/22004129
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors: implications for schizophrenia (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717536/
Identity Formation, Marijuana and “The Self”: A Study of Cannabis Normalization among University Students (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847659/
top
Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855086/
Perception of tobacco, cannabis, and alcohol use of others is associated with one’s own use (full–2013) http://www.ascpjournal.org/content/8/1/15
Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584982/
Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947129/
Cannabis Use, Employment, and Income: Fixed-Effects Analysis of Panel Data (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867578/
CB1 receptor signaling regulates social anxiety and memory (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12045/full
THE IMPORTANCE OF FAMILY RELATIONS FOR CANNABIS USERS: THE CASE OF SERBIAN ADOLESCENTS (full–2013) http://www.sid.ir/en/VEWSSID/J_pdf/86320130302.pdf
Higher rates of adolescent substance use in child welfare versus community populations in the United States (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817044/
The role of child protection in cannabis grow-operations (full–2013)  www.canorml.org/child.welfare.pdf 
Can Marijuana Reduce Social Pain? (full–2013)  http://journals.sagepub.com/doi/full/10.1177/1948550613488949 
Identity formation, marijuana and “the self”: a study of cannabis normalization among university students (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847659/
The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) (full-2013)  http://journal.frontiersin.org/Journal/10.3389/fnbeh.2013.00100/full#B12
Cannabis use during a voluntary quit attempt: An analysis from ecological momentary assessment (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770798/

The role of cannabinoid 1 receptor expressing interneurons in behavior (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946968/ 
From “Social Supply” to “Real Dealing”:Drift, Friendship, and Trust in Drug-Dealing Careers (link to PDF–2013)  http://search.proquest.com/openview/7fca7d95539590726bcef9c62d624c4c/1?pq-origsite=gscholar&cbl=34918
Creativity in cannabis-users and in drug addicts in maintenance treatment and in rehabilitation (abst in English & German–2013)  https://link.springer.com/article/10.1007%2Fs40211-012-0045-3
Illegal drugs and delinquency (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23434380 
Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23669059
CB1 cannabinoid receptor-mediated aggressive behavior (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0028390813003304
Cannabis use motives and personality risk factors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24368004
Cannabis use in a Swiss male prison: Qualitative study exploring detainees’ and staffs’ perspectives (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23773686
Dominant negative DISC1 mutant mice display specific social behaviour deficits and  aberration in BDNF and cannabinoid receptor expression (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24219803 

The Effect of Medical Marijuana Laws on Crime: Evidence from State Panel Data, 1990-2006 (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0092816
Genetic Variations in the Human Cannabinoid Receptor Gene Are Associated with Happiness (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093771
Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125187/
top

An Examination of Opinions Toward Marijuana Policies Among High School Seniors in the United States (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220268/ 
Marijuana Policy in Colorado (full–2014) http://object.cato.org/sites/cato.org/files/pubs/pdf/working-paper-24_2.pdf
Acute alcohol use temporally increases the odds of male perpetrated dating violence: A 90-day diary analysis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858531/
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users (full 014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398332/
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963405/
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (full–2014) http://www.nature.com/tp/journal/v4/n7/full/tp201453a.html
Couples’ Marijuana Use Is Inversely Related to Their Intimate Partner Violence Over the First 9 Years of Marriage (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282761/ 
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats (full–2014) http://ijnp.oxfordjournals.org/content/18/6/pyu111
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat (full-2014) http://ijnp.oxfordjournals.org/content/18/3/pyu104.long
Risk-taking in schizophrenia and controls with and without cannabis dependence (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308438/
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (full–2014)  http://www.nature.com/npp/journal/v40/n6/full/npp2014329a.html 
Interpersonal Guilt and Substance Use in College Students (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782605/ 
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion (full–2014) http://www.nature.com/tp/journal/v4/n9/full/tp201477a.html
Social anxiety and coping motives for cannabis use: The impact of experiential avoidance (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149405/

Cannabis Use Behaviors and Social Anxiety: The Roles of Perceived Descriptive and Injunctive Social Norms (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893635/ 
Individual differences in response to positive and negative stimuli: endocannabinoid-based insight on approach and avoidance behaviors (full–2014)  http://journal.frontiersin.org/Journal/10.3389/fnsys.2014.00238/full 
Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332795/
Cannabis and related impairment: the unique roles of cannabis use to cope with social anxiety and social avoidance (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240501/ 
Cannabis Use and its Effects on Health, Education and Labor Market Success (link to PDF-2014) http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2414469
Strain and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24933531
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24980155
Socialization Instances Linked to Cannabis Experimentation Among French Teenagers (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25099311
The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol (abst–2014) http://www.psy-journal.com/article/S0165-1781(14)00831-2/fulltext
Frequent electronic media communication with friends is associated with higher adolescent substance use (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25471077
Involvement of 2-arachidonoylglycerol signaling in social challenge responding of male CD1 mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25547462
top

Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25024347
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24698342 

The influence of personality on the sensitivity to subjective effects of Δ9-tetrahydrocannabinol (abst–2014) http://www.psy-journal.com/article/S0165-1781(14)00831-2/fulltext
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421

Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
Stigma among California’s Medical Marijuana Patients (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341951/
To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681836/
Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety like behavior and sociability (full–2015) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00235/full
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441859/
Young adult cannabis users report greater propensity for risk-taking only in non-monetary domains (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297698/ 
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (full–2015) http://www.sciencedirect.com/science/article/pii/S0149763415001244
Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592162/
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604232/
Prevalence of Marijuana-Related Traffic on Twitter, 2012-2013: A Content Analysis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491148/
Twitter Chatter about Marijuana (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306811/
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646225/
Cannabidiol as a Potential Treatment for Anxiety Disorders (full–2015) http://link.springer.com/article/10.1007/s13311-015-0387-1
Effects of amphetamine, morphine, and CP 55, 940 on Go/No-Go task performance in rhesus monkeys (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497858/
Maternal separation and early stress cause long-lasting effects on dopaminergic and  endocannabinergic systems and alters dendritic morphology in the nucleus accumbens  and frontal cortex in rats (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/dneu.22361/full
Cannabis use in early adolescence: Evidence of amygdala hypersensitivity to signals of  threat (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801124/ 

Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.0050269
Longitudinal associations between social anxiety symptoms and cannabis use throughout adolescence: the role of peer involvement (full–2015) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854944/
Early onset of cannabis use: Does personality modify the relation with changes in  perceived parental involvement? (click “academia” for download–2015)  https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Early+onset+of+cannabis+use%3A+Does+personality+modify+the+relation+with+changes+in+perceived+parental+involvement%3F+++++++++++++++&btnG
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0149763415001244
The role of the Cannabinoid Receptor 1 in adolescents’ processing of facial expressions  (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26527537

Dissecting the cannabinergic control of behavior: The where matters (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26260530
Role of CB2 receptors in social and aggressive behavior in male mice (abst–2015) http://link.springer.com/article/10.1007%2Fs00213-015-3939-5
From substance use to homelessness or vice versa? (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0277953615002786U
Use and effects of cannabinoids in military veterans with post-traumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26391492
top
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26706691
Who receives cannabis use offers: A general population study of adolescents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26433564
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26747370
Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26212076
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Investigating cannabis use normalization by distinguishing between experimental and regular use: a multilevel study in 31 countries (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25785792
Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25034429
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social  behavior and emotionality at different developmental ages in rats (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25914159 

Subjective and behavioral effects of marijuana the morning after smoking (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/2315429
Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914428/ 

Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745
Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803149/
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00203/full
Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110529/
Solitary cannabis use frequency mediates the relationship between social anxiety and cannabis use and related problems (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147422/
Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13645/full
Discriminability of personality profiles in isolated and Co-morbid marijuana and nicotine users (full–2016) http://www.psy-journal.com/article/S0165-1781(16)30273-6/fulltext
Lipids in psychiatric disorders and preventive medicine (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303353
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869705/ 

Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013 (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957692/ 
Neural mechanisms of sensitivity to peer information in young adult cannabis users (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955693/ 
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice (full–2016) http://www.ncbi.nlm.nih.gov/pubmed/26873082
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461973/ 
Neural endocannabinoid CB1 receptor expression, social status, and behavior in male European starlings (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904780/ 
The Effect of Medical Marijuana on Sickness Absence (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27416978 
A Genetic Component to National Differences in Happiness (abst–2016) http://link.springer.com/article/10.1007/s10902-015-9712-y
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
From “herbal highs” to the “heroin of cannabis”: Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum (abst–2016) http://www.sciencedirect.com/science/article/pii/S0955395916000347
Social defeat leads to changes in the endocannabinoid system; an overexpression of calreticulin and motor impairment in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816300328
Cross-section and panel estimates of peer effects in early adolescent cannabis use: With a little help from my ‘friends once removed’ (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0277953616303021 

Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597 (abst–2016) http://www.sciencedirect.com/science/article/pii/S0168010216300220
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27157075
Cannabis and Alcohol Use, Affect, and Impulsivity in Psychiatric Outpatients’ Daily Lives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27270874
Traffic accidentability and risky driving behavior in young people in New Caledonia. Results of study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27259836
The neurobiology of social play and its rewarding value in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416303724
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816308660
Risky substance use and peer pressure in Swiss young men: Test of moderation effects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27632359
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst–2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
UPPS-P model impulsivity and marijuana use behaviors in adolescents: A meta-analysis (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30923-1/abstract
Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27750184
The neurobiology of social play and its rewarding value in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416303724
Determining Cannabis Use Status From a Photograph: An Assessment of the “Jay-dar” in Neuropsychologists (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27779445
A social network analysis of substance use among immigrant adolescents in six European cities (abst–2016) http://www.sciencedirect.com/science/article/pii/S027795361630538X
Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population? (abst–2016) http://www.sciencedirect.com/science/article/pii/S089142221630230X
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28008372
Genetic polymorphisms in genes related to risk-taking behaviours predicting body mass  index trajectory among Mexican American adolescents (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27228958
Using Attitudes, Age and Gender to Estimate an Adolescent’s Substance Use Risk (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5417548/ 

Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for  Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272923/ 
Cannabinoid Receptor 1 and Fatty Acid Amide Hydrolase Contribute to Operant Sensation Seeking in Mice (full–2017) http://www.mdpi.com/1422-0067/18/8/1635
Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana (full–2017)  http://pediatrics.aappublications.org/content/139/4/e20162675.long 
Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531370/ 
The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models (full–2017) http://www.mdpi.com/1422-0067/18/9/1916/htm 
Endocannabinoid system in sexual motivational processes: is it a novel therapeutic horizon? (full–2017) http://www.sciencedirect.com/science/article/pii/S1043661816312385
Social Isolation in Early versus Late Adolescent Mice Is Associated with Persistent  Behavioral Deficits That Can Be Improved by NeurosteroidBased Treatment (full2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581875/
Effects of cannabis use and subclinical depression on the P3 eventrelated potential in an emotion processing task (full2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371467/
Chronic Adolescent Δ9Tetrahydrocannabinol Treatment of Male Mice Leads to LongTerm Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent  Cannabidiol (full2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655843/  Treatment seeking in cannabis dependence: The role of social cognition (full2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(16)31002-X/fulltext
Assessing the experience of using synthetic cannabinoids by means of interpretative  phenomenological analysis (full2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303230/
Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist,  rimonabant, on emotional processing (download2017) thcint.com
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA (full–2017) http://journals.sagepub.com/doi/abs/10.1177/0269881116684336?url_ver=Z39.88- 2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Modelling possible causality in the associations between unemployment, cannabis use, and alcohol misuse (abst–2017) http://www.sciencedirect.com/science/article/pii/S0277953617300011
Cannabis use and dating violence among college students: A call for research (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28109121
Social factors in marijuana use for medical and recreational purposes (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(16)30618-7/fulltext
Alternate policing strategies: Cost-effectiveness of cautioning for cannabis offences (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28139329
Cannabinoids activate monoaminergic signaling to modulate key C. elegans behaviors (abst–2017) http://www.jneurosci.org/content/37/11/2859.long

URB597 reduces biochemical, behavioral and morphological alterations in two  neurotoxic models in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28157650 
Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor (abst–2017)  http://link.springer.com/article/10.1007%2Fs00213-017-4548-2 
The endocannabinoid system modulating levels of consciousness, emotions and likely dream contents (abst–2017) http://www.eurekaselect.com/150392/article
Pharmacological inhibition of FAAH modulates TLR-induced neuroinflammation, but not sickness behaviour: An effect partially mediated by central TRPV1 (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28237711 

Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28230072
Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28319590
Substance Use in Undergraduate Students With Histories of Attention-Deficit / Hyperactivity Disorder (ADHD): The Role of Impulsivity (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28406351 

Lifelong imbalanced LA/ALA intake impairs emotional and cognitive behavior via  changes in brain endocannabinoid system (abst–2017)  http://www.jlr.org/content/58/2/301.abstract 
Characteristics of socially withdrawn youth in France: A retrospective study (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28446040 
High times for cannabis: Epigenetic imprint and its legacy on brain and behavior (abst–2017) http://www.sciencedirect.com/science/article/pii/S0149763417300659
Nucleus Accumbens Functional Connectivity at Age 20 is Associated with Trajectory of  Adolescent Cannabis Use and Predicts Psychosocial Functioning in Young Adulthood  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28547854
Associations of anxiety sensitivity and emotional symptoms with the subjective effects of alcohol, cigarettes, and cannabis in adolescents (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28544955
Endocannabinoid Signaling in the Control of Social Behavior (abst–2017)  http://www.cell.com/trends/neurosciences/abstract/S0166-2236(17)30077-2
Blunted stress reactivity in chronic cannabis users (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4648-z
Recommendation to reconsider examining cannabis subtypes together due to opposing  effects on brain, cognition and behavior (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28579491
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) http://www.drugandalcoholdependence.com/article/S0376-8716(17)30220-X/fulltext
Family Structure and Adolescent Substance Use: An International Perspective (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605218
Associations of Bullying and Cyberbullying With Substance Use and Sexual Risk Taking
in Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605163
How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning (abst–2017)  http://journals.sagepub.com/doi/abs/10.1177/1087054716685842?url_ver=Z39.882003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Daily associations between cannabis motives and consumption in emerging adults Cannabis use, attitudes, and legal status in the U.S.: A review (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28705601
Smoked marijuana attenuates performance and mood disruptions during simulated night shift work (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30309-5/fulltext
Adolescent peer networks and the moderating role of depressive symptoms on  developmental trajectories of cannabis use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28738220
Substance Use in Young Swiss Men: The Interplay of Perceived Social Support and  Dispositional Characteristics (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28379109
Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse  hippocampus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28888955
Social factors in marijuana use for medical and recreational purposes (abst–2017) http://www.epilepsybehavior.com/article/S1525-5050(16)30618-7/fulltext
The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further  evidence for transporter-mediated endocannabinoid release (abst–2017)  https://www.sciencedirect.com/science/article/pii/S002839081730549X?via%3Dihub
Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic  deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids
imbalance (abst–2017)  http://www.jneurosci.org/content/early/2017/06/20/JNEUROSCI.3516-16.2017
Motivational changes of cannabis use prior to and during the course of schizophrenia  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28004866
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599212
Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction  Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29265107
Activation of the cannabinoid system in the nucleus accumbens affects effort-based  decision making (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0091305717301387?via%3Dihub
Four Mechanistic Models of Peer Influence on Adolescent Cannabis Use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29104847
Inspired by Mary Jane? Mechanisms underlying enhanced creativity in cannabis users  (abst–2017) https://www.sciencedirect.com/science/article/pii/S1053810017303744?via%3Dihub
The Intergenerational Transmission of Cannabis Use: Associations Between Parental  History of Cannabis Use and Cannabis Use Disorder, Low Positive Parenting, and  Offspring Cannabis Use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29189023
Effects of CB1 receptor antagonism and stress exposures in adolescence on  socioemotional behaviours, neuroendocrine stress responses, and expression of relevant proteins in the hippocampus and prefrontal cortex in rats (full–2018)  https://www.sciencedirect.com/science/article/pii/S0028390817304963?via%3Dihub
Cannabinoids induce apathetic and impulsive patterns of choice through CB1 receptors  and TRPV1 channels (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29355640
Characterizing Blunt Smokers by Their Acquisition of Cannabis (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29300122
Does social context matter? An ecological momentary assessment study of marijuana use among college students (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0306460318300042?via%3Dihub 


SOCIAL ANXIETY
Marijuana craving during a public speaking challenge: Understanding marijuana use  vulnerability among women and those with social anxiety disorder (full–2010)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981668/
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety  disorder: a preliminary report (full-2010)  https://www.researchgate.net/publication/46191395_Neural_basis_of_anxiolytic_effects_of_cannabidiol_CBD_in_generalized_social_anxiety_disorder_A_preliminary_report
Social Anxiety and Marijuana-Related Problems: The Role of Social Avoidance (full–2011) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981690/
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/
Cannabidiol in humans-the quest for therapeutic targets (full–2012)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763649/
Social Anxiety and Cannabis Use: An Analysis from Ecological Momentary Assessment  (full–2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268873/
The Relationship between Cannabis Use Disorders and Social Anxiety Disorder in the  National Epidemiological Study of Alcohol and Related Conditions (NESARC) (full–2012) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350824/
Marijuana-related problems and social anxiety: the role of marijuana behaviors in social  situations (abst–2012)  https://www.ncbi.nlm.nih.gov/pubmed/22004129
The impact of comorbid cannabis use disorders on the clinical presentation of social  anxiety disorder (abst–2012)  https://www.ncbi.nlm.nih.gov/pubmed/22047609
Cannabis-related impairment and social anxiety: the roles of gender and cannabis use  motives (abst–2012)  https://www.ncbi.nlm.nih.gov/pubmed/22766487
CB1 receptor signaling regulates social anxiety and memory (full–2013)  http://onlinelibrary.wiley.com/doi/10.1111/gbb.12045/full
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539121/
Social anxiety and coping motives for cannabis use: The impact of experiential  avoidance (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149405/
Cannabis Use Behaviors and Social Anxiety: The Roles of Perceived Descriptive and  Injunctive Social Norms (full-2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893635/
Cannabis and related impairment: the unique roles of cannabis use to cope with social  anxiety and social avoidance (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240501/
Social anxiety and cannabis cravings: The influences of parent injunctive norms and  tension reduction expectancies (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646225/
Longitudinal associations between social anxiety symptoms and cannabis use  throughout adolescence: the role of peer involvement (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854944/
A longitudinal study of cannabis use initiation among high school students: Effects of  social anxiety, expectancies, peers and alcohol (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/25800726
Cannabis craving in response to laboratory-induced social stress among racially diverse  cannabis users: The impact of social anxiety disorder (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147424/
Solitary cannabis use frequency mediates the relationship between social anxiety and  cannabis use and related problems (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147422/
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and  Parent Descriptive and Injunctive Normative Perceptions (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869705/
An Examination of Social Anxiety in Marijuana and Cigarette Use Motives Among  Adolescents (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851246/
Mediating Effects of Global Negative Effect Expectancies on the Association between  Problematic Cannabis Use and Social Anxiety (full–2017)  https://www.frontiersin.org/articles/10.3389/fpsyt.2017.00249/full
Is there a role for cannabidiol in psychiatry? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28112021
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599212
Four Mechanistic Models of Peer Influence on Adolescent Cannabis Use (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29104847


SOCIAL MEDIA/INTERNET
The identification of rimonabant polymorphs, sibutramine and analogues of both in counterfeit Acomplia bought on the internet (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20828968
Patterns of synthetic cannabinoid use in Australia (full–2012)  http://onlinelibrary.wiley.com/doi/10.1111/j.1465-3362.2012.00519.x/full
Internet Highs-Seizures After Consumption of Synthetic Cannabinoids Purchased Online (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22824736
Effectiveness of a self-guided web-based cannabis treatment program: randomized controlled trial (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636012/ Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855086/
Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use  (full–2013) http://www.ijdp.org/article/S0955-3959%2813%2900135-7/fulltext
UR-144 in products sold via the Internet: Identification of related compounds and characterization of pyrolysis products (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23315949
Use of Silk Road, the online drug marketplace, in the UK, Australia and the USA (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24372954
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS) (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641512/
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Frequent electronic media communication with friends is associated with higher adolescent substance use (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25471077
A dawning demand for a new cannabis policy: A study of Swedish online drug
discussions (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24794114

Prevalence of Marijuana-Related Traffic on Twitter, 2012-2013: A Content Analysis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491148/
Twitter Chatter about Marijuana (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306811/
Cannabis Mobile Apps: A Content Analysis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705020/
Using Web searches to track interest in synthetic cannabinoids (aka ‘herbal incense’) (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412351/
“Time for dabs”: Analyzing Twitter data on marijuana concentrates across the US. (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581982/
Displays of dabbing marijuana extracts on YouTube (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716(15)01613-0/abstract
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric  epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
Cannabis: a self-medication drug for weight management? The never ending story (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26456495
Online survey characterizing vaporizer use among cannabis users (abst–2015)  http://www.drugandalcoholdependence.com/article/S0376-8716(15)01835-9/abstract
Tracking Dabbing Using Search Query Surveillance: A Case Study in the United States (full–2016) http://www.jmir.org/2016/9/e252/
Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028912/
“When ‘Bad’ is ‘Good'”: Identifying Personal Communication and Sentiment in Drug Related Tweets. (full – 2016) http://publichealth.jmir.org/2016/2/e162/
“I Use Weed for My ADHD”: A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0156614
From “herbal highs” to the “heroin of cannabis”: Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum (abst–2016) http://www.sciencedirect.com/science/article/pii/S0955395916000347
“Those edibles hit hard”: Exploration of Twitter data on cannabis edibles in the US. (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716%2816%2930056-4/abstract
Assessing the Validity of Online Drug Forums as a Source for Estimating Demographic and Temporal Trends in Drug Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27466069
Exploring Marijuana Advertising on Weedmaps, a Popular Online Directory (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27534665
Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27611957
Examination of YouTube videos related to synthetic cannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27639268
The Synthetic Cannabinoids Phenomenon (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27655416
“It Takes Longer, but When It Hits You It Hits You!”: Videos About Marijuana Edibles on YouTube (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502544/
Cannabis Users’ Recommended Warnings for Packages of Legally Sold Cannabis: An  Australia-Centered Study (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531364/
Patterns of Twitter Behavior Among Networks of Cannabis Dispensaries in California  (full–2017) http://www.jmir.org/2017/7/e236/
Medical Decision-Making Processes and Online Behaviors Among Cannabis Dispensary  Staff (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570116/
Comparison of brief versus extended personalised feedback in an online intervention for cannabis users: Short-term findings of a randomised trial (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28162849
Acceptability and effectiveness of a web-based psychosocial intervention among criminal justice involved adults (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28285466
The illegal synthetic cannabinoid drug market in Israel – evolution and new challenges  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28530077
Increased in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28578250
Associations of Bullying and Cyberbullying With Substance Use and Sexual Risk Taking  in Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28605163
A market on both “sides” of the law: The use of the hidden web for the sale of new  psychoactive substances (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28617997
Online self-help forums on cannabis: A content assessment (abst–2017) http://www.pec-journal.com/article/S0738-3991(17)30345-2/fulltext
Utilizing Big Data and Twitter to Discover Emergent Online Communities of Cannabis  Users (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28615950
User characteristics and effect profile of Butane Hash Oil: An extremely high-potency  cannabis concentrate (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30255-7/fulltext
Exposure to and Content of Marijuana Product Reviews (abst–2017)  https://link.springer.com/article/10.1007%2Fs11121-017-0818-9
“I feel like I’ve hit the bottom and have no idea what to do”: Supportive social networking on Reddit for individuals with a desire to quit cannabis use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28704167
Characterizing marijuana concentrate users: A web-based survey (abst–2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30311-3/fulltext
Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based  investigation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28735833
Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing  relationship? (abst–2017) http://www.ijdp.org/article/S0955-3959(17)30292-X/fulltext
Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use  in older adults with and without HIV infection (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317303878?via%3Dihub
The efficacy of computerized interventions to reduce cannabis use: A systematic review  and meta-analysis (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317304537?via%3Dihub
“You got to love rosin: Solventless dabs, pure, clean, natural medicine.” Exploring Twitter data on emerging trends in Rosin Tech marijuana concentrates (abst-2017)  http://www.drugandalcoholdependence.com/article/S0376-8716(17)30604-X/fulltext
The Effects of Social Presence on Adherence-Focused Guidance in Problematic Cannabis  Users: Protocol for the CANreduce 2.0 Randomized Controlled Trial (full–2018)  http://www.researchprotocols.org/2018/1/e30/


SPACEFLIGHT/OUTER SPACE
Effects of parabolic flight and spaceflight on the endocannabinoid system in humans (download–2012) https://pdfs.semanticscholar.org/700c/01d83f2bc080f6ba242cc9c927394f5bf111.pdf
Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00429-016-1345-3


SPASTICITY*+
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835560/?tool=pmcentrez
Standardized Cannabis in Multiple Sclerosis: A Case Report (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on  spasticity in persons with spinal cord injury (full-2010) http://www.archives-pmr.org/article/S0003-9993%2810%2900072-9/fulltext
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis (link to download-2010)
https://www.researchgate.net/publication/44683223_Metaanalysis_of_the_efficacy_and_safety_of_Sativex_nabiximols_on_spasticity_in_people_with_multiple_sclerosis
Role of cannabinoids in the treatment of pain and (painful) spasticity (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21142261
Dronabinol for the treatment of unspecific pain, restlessness and spasticity in neuropaediatrics (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1265622
top
Pharmacological Management of Pain in Patients with Multiple Sclerosis (abst–2010) https://link.springer.com/article/10.2165%2F11537930-000000000-00000
Emerging treatment options for spasticity in multiple sclerosis; clinical utility of cannabinoids (link to PDF–2011) http://www.dovepress.com/articles.php?article_id=7675
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®)), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=322
THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21456949/abstract/THC_and_CBD_oromucosal_spray__Sativex%C2%AE__in_the_management_of_spasticity_associated_with_multiple_sclerosis_
Cannabinoids in children (abst–2011)  http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=295
FROM GHENNAB TO CANNABIS: HOPES TO FIND A CURE FOR MULTIPLE SCLEROSIS ARE FLOURISHING (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=228000
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’ (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22646020
Early exposure to Environmental enrichment alters the expression of genes of the  endocannabinoid system (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21419109/abstract/Early_exposure_to_Environmental_enrichment_alters_the
_expression_of_genes_of_the_endocannabinoid_system_
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
A placebo-controlled, parallel-group, randomized withdrawal study of subjects with
symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols) (full–2012) http://msj.sagepub.com/content/18/2/219.long
Evaluation of the Effects of Sativex (THC BDS: CBD BDS) on Inhibition of Spasticity in a Chronic Relapsing Experimental Allergic Autoimmune Encephalomyelitis: A Model of Multiple Sclerosis (full–2012)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423911/
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial (full–2012) http://www.cmaj.ca/content/184/10/1143.long
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437528/
Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22509985
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/25876933
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22954177
What place for cannabis extract in MS? (abst–2012) http://dtb.bmj.com/content/50/12/141.abstract
Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of  cannabinoids (abst in English–2012)  http://www.ncbi.nlm.nih.gov/pubmed/23011861
(abst in Spanish) https://www.neurologia.com/articulo/2012362
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23072659
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report  (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22726074
A questionnaire survey of patients and carers of patients prescribed Sativex as an  unlicensed medicine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22784399
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System  (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22583441
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis (full–2013)  http://zl.elsevier.es/en/revista/neurologia-495/articulo/clinical-experiences-with-cannabinoids-in-90328787
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists (full–2013) http://www.fasebj.org/content/28/1/117.long
top
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in  multiple sclerosis-related spasticity: a case report (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625014/
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a  randomised, placebo-controlled trial (full–2013)  http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(13)70159-5/fulltext
Control of experimental spasticity by targeting the degradation of endocannabinoids  using selective fatty acid amide hydrolase inhibitors. (link to download–2013)  https://www.researchgate.net/publication/236460848_Control_of_experimental_spasticity_by_targeting_the_degradation_of_endocannabinoids_using_selective_fatty_acid_amide_hydrolase_inhibitors
Endocannabinoid system modulator use in everyday clinical practice in the UK and  Spain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23369054
A new multiple sclerosis spasticity treatment option: effect in everyday clinical practice and cost-effectiveness in Germany (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23369055
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22878432
Who Benefits Most from THC:CBD Spray? Learning from Clinical Experience (full–2014) http://www.karger.com/Article/FullText/357743
THC:CBD Spray and MS Spasticity Symptoms: Data from Latest Studies (full–2014) http://www.karger.com/Article/FullText/357742
Advances in the management of multiple sclerosis spasticity: experiences from recent studies and everyday clinical practice (full–2014)  http://www.karger.com/Article/Pdf/367615
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary (full–2014) http://www.clinicaltherapeutics.com/article/S0149-2918%2814%2900684-5/fulltext
Clinical experience with THC:CBD oromucosal spray in patients with multiple sclerosisrelated spasticity (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24392812
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice – Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24525548
Delta-9-Tetrahydrocannabinol/Cannabidiol (Sativex®): A Review of Its Use in Patients with Moderate to Severe Spasticity Due to Multiple Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24671907
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24943098
Delta-9-tetrahydrocannabinol + cannabidiol. A reasonable option for some patients with multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25121144
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
“Disease Modifying Nutricals” for multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25435020
Cannabinoid mouth spray brought help to a severely spastic young man (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/25158585
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Cortico-spinal Modulation (full–2015) http://www.hindawi.com/journals/np/2015/656582/
top

Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015)
http://jama.jamanetwork.com/article.aspx?articleid=2338251
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (full–2015)  http://cannabisclinicians.org/wp-content/uploads/2015/07/JAMA-Chronic-Pain-2015.pdf
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507161/
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549715/
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604175/
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015)  http://jama.jamanetwork.com/article.aspx?articleid=2338230

Drug-resistant MS spasticity treatment with Sativex® add-on and driving ability (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25208898
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796592
Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26126926
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Cannabinoids for the Treatment of Movement Disorders (abst–2015)
https://link.springer.com/article/10.1007%2Fs11940-015-0370-5
Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis (abst–2015) http://informahealthcare.com/doi/abs/10.1586/14737175.2015.1067607
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
Use of Cannabinoids for Spasticity and Pain Management in MS (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26705757

Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis  Spasticity in Italy: First Data from a Large Observational Study (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26571097
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26289497
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life  Italian monocentric study (abst–2015) http://link.springer.com/article/10.1007/s10072-015-2392-x
Walking improvements with nabiximols in patients with multiple sclerosis (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26239223
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710104/
top

THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms (full–2016) http://www.karger.com/Article/FullText/444235
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain (full–2016) http://www.karger.com/Article/FullText/444234
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity (full–2016) http://jnnp.bmj.com/content/early/2016/05/08/jnnp-2015-312591.long
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270417/
The use of medical-grade cannabis in patients non-responders to Nabiximols (first page–2016) http://www.jns-journal.com/article/S0022-510X(16)30472-5/abstract
A cost-effectiveness model for the use of a cannabis-derived oromucosal spray for the treatment of spasticity in multiple sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26750641
Nabilone for the Management of Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26923810
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27003093
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27160412
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30056-6/abstract
Role of nurses in the managements of symptoms associated with spasticity in patients with multiple sclerosis (abst in English & Spanish–2016) http://www.elsevier.es/es-revista-enfermeria-clinica-35-articulo-manejo-los-sintomas-asociados-espasticidad-S1130862116300882
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray (abst–2016) http://www.jns-journal.com/article/S0022-510X(16)30620-7/fulltext
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) http://www.eurekaselect.com/146891/article
Medical Marijuana: Just the Beginning of a Long, Strange Trip? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27660328
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30171-7/fulltext
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of  THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity (abst–2016)  https://www.karger.com/Article/Abstract/445943
Muscle elastography: a new imaging technique for multiple sclerosis spasticity  measurement (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27904961
Cannabis and Multiple Sclerosis—The Way Forward (full–2017)  http://journal.frontiersin.org/article/10.3389/fneur.2017.00299/full
Understanding Patients’ Process to Use Medical Marijuana: A Southern New Jersey  Community Engagement Project (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513646/
A randomised controlled cross-over double-blind pilot study protocol on THC:CBD  oromucosal spray efficacy as an add-on therapy for post-stroke spasticity (full–2017) http://bmjopen.bmj.com/content/7/9/e016843.long
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues  for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Cannabis use in persons with traumatic spinal cord injury in Denmark (full-2017) https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2105
The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis:  Rationale, study design, and methodology (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704890/
Systematic review of safeness and therapeutic efficacy of cannabis in patients with  multiple sclerosis, neuropathic pain, and in oncological patients treated with  chemotherapy (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29119763 (full in Italian)  http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabisEffects
on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-
Tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189366
Cannabinoids therapeutic use: what is our current understanding following the  introduction of THC, THC:CBD oromucosal spray and others? (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28276775
Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review  and meta-analysis of randomized clinical trials (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28917371
Delta-9-tetrahydrocannabinol-cannabidiol in the treatment of spasticity in chronic spinal cord injury: a clinical experience (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28929471
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain  management – An overview of systematic reviews (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29034533
THC/CBD oromucosal spray in patients with multiple sclerosis overactive bladder: a pilot prospective study (abst–2017)  https://link.springer.com/article/10.1007%2Fs10072-017-3148-6
Sativex in the management of multiple sclerosis-related spasticity: An overview of the
last decade of clinical evaluation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29055461
Medical cannabis for the treatment of chronic pain and other disorders: misconceptions
and facts (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29067992
The therapeutic effects of Cannabis and cannabinoids: An update from the National  Academies of Sciences, Engineering and Medicine report (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29325791


SPINAL CORD INJURY*+
Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826109
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869361/
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury (full–2010) http://www.archives-pmr.org/article/S0003-9993%2810%2900072-9/fulltext
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20156559
Control of bone remodeling by nervous system. Nervous system and bone (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21123931
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172222/?tool=pubmed
Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235339/
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159760/
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury (abst–2011) http://www.fasebj.org/content/25/1_Supplement/lb422.abstract?sid=ebd6611b-9cd5-451c-8d4c-a78d4d17cca1
Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions (abst–2011) https://www.ncbi.nlm.nih.gov/pubmed/21265596
top
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21915768
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22210507
EFFECT OF AQUATIC EXTRACT OFCANNABIS SATIVA LEAVES ON DEGENERATION OF ALPHA MOTONEURONS IN SPINAL CORD AFTER SCIATIC NERVE COMPRESSION IN RATS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258699
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265030/?tool=pubmed
Site-specific and time-dependent activation of the endocannabinoid system after  transection of long-range projections (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310878/?tool=pubmed
Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and  restores basal cytokine levels (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603341/
A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma  of the rat spinal cord (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22791629
The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22201038
Specific inhibition of the JNK pathway promotes locomotor recovery and neuro-protection after mouse spinal cord injury (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22426389
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full–2013) http://www.jneuroinflammation.com/content/10/1/20
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full–2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full–2013) http://www.jneuroinflammation.com/content/10/1/91
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full–2013) http://www.sciencedirect.com/science/article/pii/S0306452213007835
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF–2013) http://www.eurekaselect.com/107976/article
Medicinal Cannabis and Painful Sensory Neuropathy (editorial–2013) http://journalofethics.ama-assn.org/2013/05/oped1-1305.html
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23981015
Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979158/
top

Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia (full–2014) http://www.sciencedirect.com/science/article/pii/S0306452213010531
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014364a.html
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0113161
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184706/
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844071/
Endocannabinoid system and pain: an introduction (full–2014)  https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/endocannabinoid-system-and-pain-anintroduction/4C5678CCAD813D1C978C676155E9E39D/core-reader
Report on Medical Cannabis Research, What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25064178
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Spinal RGS4 inhibition effectively attenuates neuropathic hyperalgesia and restores cannabinoid receptor type 1 signaling (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13324/full
Cannabinoids to treat spinal cord injury (abst–2015) http://www.sciencedirect.com/science/article/pii/S0278584615000573
CB 1Cannabinoid Receptor Agonist Inhibits Matrix Metalloproteinase Activity in Spinal Cord Injury: A Possible Mechanism of Improved Recovery (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0304394015002979
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis (link to PDF–2016) https://www.dovepress.com/a-preliminary-evaluation-of-the-relationship-of-cannabinoid-blood-conc-peerreviewed-article-JPR
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the  Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007175/
Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394015303517
The molecular mechanism and effect of cannabinoid-2 receptor agonist on the bloodspinal cord barrier permeability induced by ischemia-reperfusion injury (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26835555
A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450568
Type-2 cannabinoid receptors in neurodegeneration (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306983
Examining the Relationship Between Traumatic Brain Injury and Substance Use Outcomes in the Canadian Population (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27484302
Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27589093
Cannabis use in persons with traumatic spinal cord injury in Denmark (link to PDF- 2017) https://www.medicaljournals.se/jrm/content/abstract/10.2340/16501977-2105
Remote Ischemia Preconditioning Attenuates Blood-Spinal Cord Barrier Breakdown in  Rats Undergoing Spinal Cord Ischemia Reperfusion Injury: Associated with Activation  and Upregulation of CB1 and CB2 Receptors (full–2017)  https://www.karger.com/Article/FullText/484460
Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107590
Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe  spinal cord injury (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28479140
The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via  inhibition of GAPDH/Siah1 in a CB2-receptor dependent manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28716633
Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review  and meta-analysis of randomized clinical trials (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28917371
Delta-9-tetrahydrocannabinol-cannabidiol in the treatment of spasticity in chronic spinal cord injury: a clinical experience (abst-2017)  https://www.ncbi.nlm.nih.gov/pubmed/28929471
Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role  of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway (abst–2017) https://link.springer.com/article/10.1007%2Fs12035-017-0792-z


SPINOCEREBELLAR ATAXIA/SCA
Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145934/
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954486/
Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias (full–2014)  http://www.karger.com/Article/FullText/358127
Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3 (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717809
top


SPLEEN*+
Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte chemotaxis (full–2011) https://www.jstage.jst.go.jp/article/bpb/34/7/34_7_1090/_pdf
Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182059/
Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: Evidence from an experimental murine model (full–2011)  http://jpet.aspetjournals.org/content/early/2011/06/14/jpet.111.182717.long
Cannabinoids lead to enhanced virulence of the smallpox vaccine (vaccinia) virus (abst–2011)  http://www.unboundmedicine.com/medline/ebm/record/21131094/abstract/Cannabinoids_lead_to_enhanced_virulence_of_the_smallpox_vaccine__vaccinia__virus_
Differential Modulation by Delta(9)-Tetrahydrocannabinol (∆ (9)-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4(+) T cells (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657729/
Pharmacological inhibition of endocannabinoid degradation modulates the expression of
inflammatory mediators in the hypothalamus following an immunological stressor  (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21952131
Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120 (full–2013)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476243/
Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067587
Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687668/
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice (full–2013) http://atvb.ahajournals.org/content/33/2/215.long
Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23508466
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue (full–2014)  http://onlinelibrary.wiley.com/enhanced/doi/10.1111/bph.12298
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490613/
Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363052/
Expression Analysis of CB2-GFP BAC Transgenic Mice (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138986
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full–2015) http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
Lipopolysaccharide Suppresses Carboxylesterase 2g Activity and 2-Arachidonylglycerol Hydrolysis: A Possible Mechanism to Regulate Inflammation (abst–2015) http://www.sciencedirect.com/science/article/pii/S1098882315300125
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035052/
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27287619
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator  constitutively secreted by adrenals and in liver upon tissue damage (full–2017)  https://www.nature.com/articles/s41598-017-09808-8
Oral administration of cannabis with lipids leads to high levels of cannabinoids in the  intestinal lymphatic system and prominent immunomodulation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674070/
Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by  D-Galactose in an Aging Rats Model (full–2017)  https://www.hindawi.com/journals/ecam/2017/4757520/
A Chemoattractant-Guided Walk Through Lymphopoiesis: From Hematopoietic Stem  Cells to Mature B Lymphocytes (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28413023
FAAH, but not MAGL, inhibition modulates acute TLR3-induced neuroimmune signaling in the rat, independent of sex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28726298
Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following  Developmental Chlorpyrifos Exposure in Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28820005


SPORTS
Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20872894
top

High-performance sport, marijuana, and cannabimimetics (full–2011) http://jat.oxfordjournals.org/content/35/9/624.long
Evaluating the athlete’s claim of an unintentional positive urine drug test (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/23531893
Prevalence of Synthetic Cannabinoids in U.S. Athletes: Initial Findings (full–2012) https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/bks066
Why should Cannabis be Considered Doping in Sports? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654312/
Current knowledge on cannabinoids in oral fluid (full–2013)  http://onlinelibrary.wiley.com/doi/10.1002/dta.1514/full
Hair-based rapid analyses for multiple drugs in forensics and doping: application of dynamic multiple reaction monitoring with LC-MS/MS (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272537/
UPLC-ESI-Q-TOF-MSE identification of urinary metabolites of the emerging sport nutrition supplement methoxyisoflavone in human subjects (abst–2014) http://www.sciencedirect.com/science/article/pii/S0731708514001587
Annual banned-substance review: analytical approaches in human sports drug testing (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/dta.1769/full
Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions (abst–2015) http://link.springer.com/article/10.1007/s40279-015-0362-3
Prevalence and Correlates of Any and Frequent Synthetic Cannabinoid Use in a Representative Sample of High School Students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27191966
Synthetic Cannabinoid Use and Descriptive Norms among Collegiate Student-Athletes (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945387/
Prevalence and correlates of cannabis use among athletes-A systematic review (link to download–2016)  https://www.researchgate.net/publication/308173146_Prevalence_and_correlates_of_cannabis_use_among_athletesA_systematic_review
Prevalence and Correlates of Any and Frequent Synthetic Cannabinoid Use in a  Representative Sample of High School Students (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27191966
Cannabis: Exercise performance and sport. A systematic review (full–2017)  http://www.jsams.org/article/S1440-2440(17)30342-0/fulltext
Gender-specific associations between involvement in team sport culture and canadian  adolescents’ substance-use behavior (full–2017)  https://www.sciencedirect.com/science/article/pii/S2352827317301398?via%3Dihub


STEM CELLS/PROGENITOR CELLS +
Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099594/
Pleiotropic effects of prostaglandin E(2) in hematopoiesis; prostaglandin E(2) and other eicosanoids regulate hematopoietic stem and progenitor cell function (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206178/
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
G protein-coupled receptor crosstalk and signaling in hematopoietic stem and progenitor cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22901257
Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553153/
The Cannabinoid Receptor Type 2 as Mediator of Mesenchymal Stromal Cell Immuno-suppressive Properties (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842278/
The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health (full–2013) http://www.hindawi.com/journals/sci/2013/796715/
The effect cannabichromene on adult neural stem/progenitor cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23941747
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24076098
Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23633391
top
Modulation of subventricular zone oligodendrogenesis: a role for hemopressin? (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936357/
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart. (link to PDF–2014) http://life.scichina.com:8082/sciCe/EN/abstract/abstract513395.shtml#
Activation of Cannabinoid Receptor 2 Enhances Osteogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells (full–2015) http://www.hindawi.com/journals/bmri/2015/874982/
A cannabinoid receptor agonist N-arachidonoyl dopamine inhibits adipocyte differentiation in human mesenchymal stem cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428713/
A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways (full–2015) http://link.springer.com/article/10.1007/s11481-015-9609-x/fulltext.html
Inhibition of FAAH confers increased stem cell migration via PPARα (full-2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583083/
CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord (full–2015) http://www.nature.com/articles/srep17745
Circulating endocannabinoids during hematopoietic stem cell transplantation: A pilot study (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476410/
Cannabinoid Receptor‐2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P‐Selectin Activity (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781665/
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2 (full–2016)  http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5b%5d=7042&path%5b%5d=20008
Cannabinoid receptor 2 modulates susceptibility to experimental cerebral malaria through a CCL17-dependent mechanism (full–2016) http://www.jbc.org/content/early/2016/07/29/jbc.M116.746594.long
Cannabidiol Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297661/
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565
Cannabinoid Receptor 1 Mediates Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028843
Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301277
Regulated endosomal trafficking of Diacylglycerol lipase alpha (DAGLα) generates distinct cellular pools; implications for endocannabinoid signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S104474311630135X
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27714895
Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27918106
Activation of cannabinoid receptor type II by AM1241 protects adipose-derived
mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy
in myocardial infarction mice via Stat3 activation (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630296/
Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta adrenergic  stimulation (full–2017) http://www.exphem.org/article/S0301-472X(17)30813-5/fulltext
Regulation of human glioblastoma cell death by combined treatment of cannabidiol, γ-
radiation and small molecule inhibitors of cell signaling pathways (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650324/
Restoration of osteogenic differentiation by overexpression of cannabinoid receptor 2 in
bone marrow mesenchymal stem cells isolated from osteoporotic patients (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729701/
Decisive role of P42/44 mitogen-activated protein kinase in Δ9-tetrahydrocannabinol induced migration of human mesenchymal stem cells (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739695/
Neuroprotective properties of endocannabinoids N-arachidonoyl dopamine and Ndocosahexaenoyl dopamine examined in neuronal precursors derived from human
pluripotent stem cells (2 pages–2017)  https://link.springer.com/article/10.1134%2FS0006297917110141
Alterations of the hematologic cells in synthetic cannabinoid users (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28169460
A Chemoattractant-Guided Walk Through Lymphopoiesis: From Hematopoietic Stem  Cells to Mature B Lymphocytes (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28413023
Expression of Type I Cannabinoid Receptors at Different Stages of Neuronal  Differentiation of Human Fibroblasts (abst–2017)  https://link.springer.com/article/10.1007%2Fs10517-017-3782-2
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27778331
THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell Derived  Neurons (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29230395
Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids (full–2018)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758598/


STIFF-PERSON SYNDROME/HYPEREKPLEXIA DISEASE +
Cannabis derivatives therapy for a seronegative stiff-person syndrome: a case report (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22726074
Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019963/
top


STORAGE of CANNABIS/CANNABINOIDS
The stability of cannabis and its preparations on storage (abst–1976) http://www.ncbi.nlm.nih.gov/pubmed/6643
The decomposition of acidic and neutral cannabinoids in organic solvents (abst–1977)  http://onlinelibrary.wiley.com/doi/10.1111/j.2042-7158.1977.tb11313.x/epdf
Constituents of Cannabis sativa L. XIII: Stability of dosage form prepared by impregnating synthetic (–)-delta 9-trans-tetrahydrocannabinol on placebo Cannabis plant material (abst–1978) http://www.ncbi.nlm.nih.gov/pubmed/660481
Stability of Cannabis sativa L. samples and their extracts, on prolonged storage in Delhi (abst–1978) http://www.ncbi.nlm.nih.gov/pubmed/258607
Stability of Cannabinoids in Dried Samples of Cannabis Dating from Around 1896-1905 (abst–1990) http://www.ncbi.nlm.nih.gov/pubmed/2314109
Temperature and Moisture Content for Storage Maintenance of Germination Capacity of Seeds of Industrial Hemp, Marijuana, and Ditchweed Forms of Cannabis sativa (abst–2012)  http://www.tandfonline.com/doi/abs/10.1080/15440478.2012.737179?needAccess=true&journalCode=wjnf20
Is today’s marijuana more potent simply because it’s fresher? (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/23169764
Stability of 11 prevalent synthetic cannabinoids in authentic neat oral fluid samples: glass versus polypropylene containers at different temperatures (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23704054
Impact of oral fluid collection device on cannabinoid stability following smoked  cannabis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282833/
Determination of the relative percentage distribution of THCA and Δ9-THC in herbal  cannabis seized in Austria – Impact of different storage temperatures on stability (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247127
Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States (full–2016)  http://journal.frontiersin.org/article/10.3389/fphar.2016.00285/full#B14
Medicinal cannabis: Principal cannabinoids concentration and their stability evaluated by a high performance liquid chromatography coupled to diode array and quadrupole time of flight mass spectrometry method (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0731708516302722
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible  Brownies (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27798074
Storage and disposal of medical cannabis among patients with cancer: Assessing the risk of diversion and unintentional digestion (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27420392
Chapter 5 – Quality Control and Stability Assessment (abst–2016)  http://www.sciencedirect.com/science/article/pii/B9780128046463000059
Evaluation of long-term stability of cannabinoids in standardized preparations of  cannabis flowering tops and cannabis oil by ultra-high-performance liquid
chromatography tandem mass spectrometry (full–2017)  https://www.degruyter.com/view/j/cclm.ahead-of-print/cclm-2017-0758/cclm-2017-0758.xml
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics  studies of cannabidiolic acid (CBDA) (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0731708517322367?via%3Dihub


STRAIN INFORMATION
Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana
use among individuals ingesting dronabinol (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815025/?tool=pubmed
Standardized Cannabis in Multiple Sclerosis: A Case Report (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806860/?tool=pubmed
The draft genome and transcriptome of Cannabis sativa (full-2011)  http://genomebiology.com/content/pdf/gb-2011-12-10-r102.pdf
Investigations into the Hypothesis of Transgenic Cannabis (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/22211569
Analysis of Genetic Diversity using SSR Markers and Cannabinoid Contents in Different Varieties of Cannabis sativa L. (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1273534
VARIATIONS IN TERPENE PROFILES OF DIFFERENT STRAINS OF CANNABIS SATIVA L. (abst–2011)  http://www.actahort.org/members/showpdf?booknrarnr=925_15
Cannabis Strains: Do Cannabis Strains Differ? (article–2012) 
http://www.cannabis-med.org/index.php?tpl=faq&red=faqlist&id=278&lng=en
Cannabis – from cultivar to chemovar (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22362625
The validation of a 15 STR multiplex PCR for Cannabis species (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22573357
Extraction of high quality DNA from seized moroccan cannabis resin (hashish) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790795/
From 32 ounces to zero: a medical geographic study of dispensing a cultivated batch of “plum” cannabis flowers to medical marijuana patients in Washington State (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23909002
Cold acclimation induces distinctive changes in the chromatin state and transcript levels of COR genes in Cannabis sativa varieties with contrasting cold acclimation capacities (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25534661
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of
medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24747979

Characterisation of cannabinoid composition in a diverse Cannabis sativa L. germplasm collection (full–2015)  http://link.springer.com/article/10.1007/s10681-015-1585-y
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L. (abst–2015)  https://link.springer.com/article/10.1007%2Fs12010-014-1435-8
Size matters: evolution of large drug-secreting resin glands in elite pharmaceutical strains of Cannabis sativa (marijuana) (abst–2015) http://link.springer.com/article/10.1007/s10722-015-0254-2
Cannabis species and cannabinoid concentration preference among sleep-disturbed
medicinal cannabis users (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26151582
Two complete chloroplast genome sequences of Cannabis sativa varieties (abst–2015) http://informahealthcare.com/doi/abs/10.3109/19401736.2015.1053117
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes (full-2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00688/full
A Belated Green Revolution for Cannabis: Virtual Genetic Resources to Fast-Track Cultivar Development (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965456/
The Name of Cannabis: A Short Guide for Nonbotanists (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531363/
Transcriptome differences between fiber-type and seed-type Cannabis sativa variety
exposed to salinity (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120038/
Medical Marijuana for Epilepsy? (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911937/
Pain, Cannabis Species, and Cannabis Use Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27172585
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596302
Cannabis and Multiple Sclerosis—The Way Forward (full–2017)  http://journal.frontiersin.org/article/10.3389/fneur.2017.00299/full
Training and Practices of Cannabis Dispensary Staff (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531366/
Identification of Terpenoid Chemotypes Among High (−)-trans-Δ9-
Tetrahydrocannabinol-Producing Cannabis sativa L. Cultivars (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436332/
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol  and Cannabidiol on Human Cognition (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435777/
The Bibenzyl Canniprene Inhibits the Production of Pro-Inflammatory Eicosanoids and  Selectively Accumulates in Some Cannabis sativa Strains (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jnatprod.6b01126
Recommendation to reconsider examining cannabis subtypes together due to opposing  effects on brain, cognition and behavior (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28579491
Differentiation of Cannabis subspecies by THCA synthase gene analysis using RFLP  (abst–2017) http://www.jflmjournal.org/article/S1752-928X(17)30104-X/fulltext
Determination of Acid and Neutral Cannabinoids in Extracts of Different Strains of  Cannabis sativa Using GC-FID (abst–2017)  https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-124088


STRESS +
Endogenous cannabinoid signaling is essential for stress adaptation (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889099/?tool=pmcentrez
Motion Sickness, Stress and the Endocannabinoid System (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873996/?tool=pmcentrez
Maternal Dietary Fat Determines Metabolic Profile and the Magnitude of Endo-cannabinoid Inhibition of the Stress Response in Neonatal Rat Offspring (full–2010) http://endo.endojournals.org/content/151/4/1685.full?sid=f9729cff-d221-42d4-81d8-8545db5df878
Deficiency in Endocannabinoid Signaling in the Nucleus Accumbens Induced by Chronic Unpredictable Stress (full-2010) http://www.nature.com/npp/journal/v35/n11/full/npp201099a.html
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and
Neuroinflammation (full-2010)  http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2010214a.html
A model of endocannabinoid 2-AG-mediated depolarization-induced suppression of
inhibition (article–2010)  http://www.biomedcentral.com/content/pdf/1471-2202-11-S1-P189.pdf
Role of cannabinoids in the treatment of pain and (painful) spasticity (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/21142261
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236282/
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress (full–2011) http://www.sciencedirect.com/science/article/pii/S0091305711002310
Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress (full–2011) http://cercor.oxfordjournals.org/content/21/9/2056.full
Endocannabinoid modulation of sympathetic and cardiovascular responses to acute stress in the periaqueductal gray of the rat (full–2011)  http://ajpregu.physiology.org/content/300/3/R771
The role of cannabinoids in modulating emotional and non-emotional memory processes
in the hippocampus (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124830/?tool=pubmed
Acute Immobilization Stress Modulate GABA Release from Rat Olfactory Bulb:  Involvement of Endocannabinoids—Cannabinoids and Acute Stress Modulate GABA
Release (full–2011)  http://www.hindawi.com/journals/ijcb/2011/529851/
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat
model of intense stress (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Endocannabinoids and the cardiovascular response to stress (abst-2011)  http://www.ncbi.nlm.nih.gov/pubmed/21708837
Effects of exercise stress on the endocannabinoid system in humans under field conditions (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22101870
Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0304394011006033
Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-α Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652685/
Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice (full–2012) http://eurheartj.oxfordjournals.org/content/33/24/3124.full
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549323/
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442338/
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572464/
Neural Substrates Underlying Interactions between Appetite Stress and Reward (full–2012) https://www.karger.com/Article/FullText/338237
top
The biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: a minireview (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22540859
Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22734681
Anti-Inflammatory Effect of the Endocannabinoid Anandamide in Experimental Periodontitis and Stress in the Rat (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22777139
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0028390812004741
Age of Stress Exposure Modulates the Immediate and Sustained Effects of Repeated Stress on (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23200786
Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23237313
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22979992
Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses (full–2013) http://www.biolmoodanxietydisord.com/content/3/1/19
Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682147/
Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883309/
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (full–2013) http://ijnp.oxfordjournals.org/content/16/6/1407.long
The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830591/
Effects of Acute Stress on Cardiac Endocannabinoids, Lipogenesis, and Inflammation in Rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988664/
Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924526/
Endocannabinoid Signaling in Hypothalamic-Pituitary-Adrenocortical Axis Recovery Following Stress: Effects of Indirect Agonists and Comparison of Male and Female Mice (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929302/
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870889/
top
Amygdala FAAH and anandamide: mediating protection and recovery from stress (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169112/
Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23433741
Distress, Coping, and Drug Law Enforcement in a Series of Patients Using Medical Cannabis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23538974
Emotional, endocrine and brain anandamide response to social challenge in infant male rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23660109
Cannabinoids and glucocorticoids modulate emotional memory after stress (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0149763413001929
Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24037493
Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT₁A receptor (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23041353
Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23669059
Effects of dietary nucleotides on acute stress response and cannabinoid receptor 1  mRNAs in sole, Solea solea (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23261992
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (full–2014) http://www.nature.com/tp/journal/v4/n7/full/tp201453a.html
A role for endocannabinoids in acute stress-induced suppression of the hypothalamicpituitary-gonadal axis in male rats (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913894/
Effects of chaiyuwendan decoction on endocannabinoids levels in adipose tissue of rats with chronic stress-induced depression (full–2014) http://www.journaltcm.com/modules/Journal/contents/stories/141/16.pdf
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates (full–2014) http://www.futuremedicine.com/doi/full/10.2217/pgs.14.151
Cannabis use and anxiety: is stress the missing piece of the puzzle? (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241884/
Chronic stimulation of the tone of endogenous anandamide reduces cue – and stress induced relapse in rats (full–2014) http://ijnp.oxfordjournals.org/content/18/1/pyu025.long
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain (full–2014)  http://www.nature.com/npp/journal/v40/n2/full/npp2014198a.html
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies (full–2014)  http://journal.frontiersin.org/article/10.3389/fneur.2014.00161/full
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat (full-2014) http://ijnp.oxfordjournals.org/content/18/3/pyu104.long
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses (full–2014)  http://www.sciencedirect.com/science/article/pii/S0896627314000178
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243857/
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB (full–2014)  http://onlinelibrary.wiley.com/doi/10.1111/jnc.12716/full
Stress regulates endocannabinoid-CB1 receptor signaling (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247817/
top

Drug discovery strategies that focus on the endocannabinoid signaling system in  psychiatric disease (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696509/
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274248/
Endocannabinoid Signaling within the Basolateral Amygdala Integrates Multiple Stress Hormone Effects on Memory Consolidation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397407/
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion (full–2014) http://www.nature.com/tp/journal/v4/n9/full/tp201477a.html
Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia
with and without Concurrent Cannabis Use (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988552/
Toward a translational approach to targeting the endocannabinoid system in  posttraumatic stress disorder: A critical review of preclinical research (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465924/
When time stands still: an integrative review on the role of chronodisruption in  posttraumatic stress disorder (full–2014)  https://escholarship.org/uc/item/26d306vj
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of  pressure overload (link to download–2014)  https://www.researchgate.net/publication/263899817_P80_Cannabinoid_receptor_CB2_prevents_development_of_heart_failure_in_a_murine_model_of_pressure_overload
Endocannabinoid-mediated retrograde modulation of synaptic transmission (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747340
Endocannabinoids and energy homeostasis: An update (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24752980
Cannabinoids and schizophrenia: therapeutic prospects (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23829368
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis (abst–2014) http://www.sciencedirect.com/science/article/pii/S104366181400067X
Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24933531
Cannabinoids, endocannabinoids and stress (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch5/summary
Impact of Stress on Prefrontal Glutamatergic, Monoaminergic and Cannabinoid Systems (abst–2014)  http://link.springer.com/chapter/10.1007%2F7854_2014_331
MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure (abst–2014) http://www.sciencedirect.com/science/article/pii/S0006291X14014144
Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress (abst–2014) http://www.europeanneuropsychopharmacology.com/article/S0924-977X(14)00202-8/fulltext
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517601/
Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system (full–2015)  http://ijnp.oxfordjournals.org/content/18/8/pyv005.long
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/09/04/ijnp.pyv095.long
Targeting the endocannabinoid system to treat anxiety-related disorders (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0058/jbcpp-2015-0058.xml
Cannabis–the Israeli perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0091/jbcpp-2015-0091.xml
top
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348185/
Developmental regulation of fear learning and anxiety behavior by endocannabinoids (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12253/full
Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling (full–2015)  http://www.cell.com/neuron/fulltext/S0896-6273(15)00130-0
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403103/
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats (full–2015) http://www.jneurosci.org/content/35/41/13962.long
Mechanisms of stress in the brain (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403103/
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700831/
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522350/
Neurobiological Interactions Between Stress and the Endocannabinoid System (full–2015) http://www.nature.com/npp/journal/v41/n1/full/npp2015166a.html
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703460/
Maternal separation and early stress cause long-lasting effects on dopaminergic and
endocannabinergic systems and alters dendritic morphology in the nucleus accumbens  and frontal cortex in rats (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/dneu.22361/full
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats  (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793117/
Endocannabinoid signaling in the stress response of male and female songbirds (full–2015) http://press.endocrine.org/doi/10.1210/en.2015-1425?url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Endocannabinoid signaling integrates multiple stress hormone effects on memory (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397407/
Cannabinoids and Glucocorticoids in the Basolateral Amygdala Modulate Hippocampal Accumbens Plasticity after Stress (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748431/
Behavioral genetics: of mice, men, and internal bliss (full–2015)  http://www.cell.com/current-biology/fulltext/S0960-9822(15)00414-5
The endocannabinoid system in guarding against fear, anxiety and stress (abst–2015) https://www.ncbi.nlm.nih.gov/pubmed/26585799
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0149763415001244
Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25581607
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression (abst–2015) http://www.sciencedirect.com/science/article/pii/S0091305715000283
Acute administration of a cannabinoid CB1 receptor antagonist impairs stress-induced antinociception in fish (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25656689
Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0166432815001047
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0166432815001023
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0166432815002168
Antidepressant-like Effects of Oleoylethanolamide in a Mouse Model of Chronic Unpredictable Mild Stress (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0091305715001185
Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0278584615000986
Evidence against a critical role of CB1 receptors in adaptation of the hypothalamic pituitary-adrenal axis and other consequences of daily repeated stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26092203
Stress-related synaptic plasticity in the hypothalamus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26087679
top
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Abnormalities in neuroendocrine stress response in psychosis: the role of endo-cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26370602
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26391492
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways (abst–2015) http://www.sciencedirect.com/science/article/pii/S0014488615300959
Inhibition of anandamide hydrolysis dampens the neuroendocrine response to stress in neonatal rats subjected to suboptimal rearing conditions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26552023
Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26609670
Endocannabinoid Regulation of Neuroendocrine Systems (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638767
The Role of the Brain’s Endocannabinoid System in Pain and Its Modulation by Stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638768
Stress and memory: A selective review on recent developments in the understanding of stress hormone effects on memory and their clinical relevance (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708929
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among  Female College Students (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Mediating processes between stress and problematic marijuana use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661989
The maternal deprivation animal model revisited (abst–2015) http://www.sciencedirect.com/science/article/pii/S0149763415000172
CB1 receptors into the Prelimbic Cortex modulate food intake in rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0278584615000068
Simultaneous determination of endocannabinoids in murine plasma and brain  substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0731708515001946
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands (full–2016) http://www.hindawi.com/journals/np/2016/9815092/
2-arachidonoylglycerol signaling impairs short-term fear extinction (full–2016) http://www.nature.com/tp/journal/v6/n3/full/tp201626a.html
Cannabis use among Navy personnel in Sri Lanka: a cross sectional study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794863/
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses (full–2016) http://www.nature.com/mp/journal/vaop/ncurrent/full/mp201622a.html
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155759#pone.0155759.ref024
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (full–2016) https://elifesciences.org/content/5/e14137
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid mediated disinhibition of dopaminergic neurons (full–2016) http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Endocannabinoid-Mediated Plasticity in Nucleus Accumbens Controls Vulnerability to Anxiety after Social Defeat Stress (full–2016) http://www.cell.com/cell-reports/fulltext/S2211-1247(16)30851-8
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Impaired Ethanol- Induced Sensitization and Decreased Cannabinoid Receptor-1 in a  Model of Posttraumatic Stress Disorder (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4871361/
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related  Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00454/full
Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147424/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (full–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30715-6/fulltext
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00493/full
top
Endocannabinoids in Cerebrovascular Regulation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865067/
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid  Release in the Basolateral Amygdala (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978804/
The role of the endocannabinoid system in the brain-gut axis (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961581/
Just add water: cannabinoid discrimination in a water T-maze with FAAH(-/-) and (+/+)
mice (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937884/
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of  memory consolidation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024630/
Involvement of endocannabinoid neurotransmission in the bed nucleus of stria terminalis in cardiovascular responses to acute restraint stress in rats (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055136/
Acute effects of cannabis on breath-holding duration (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965168/
Variants in the CNR1 gene predispose to headache with nausea in the presence of life
stress (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347942/
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26778127
Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616300045
Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26786379
Social defeat leads to changes in the endocannabinoid system; an overexpression of calreticulin and motor impairment in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816300328
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function (abst–2016) http://www.psyneuen-journal.com/article/S0306-4530%2816%2930003-8/abstract
The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26809457
Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300545
Sex differences in hippocampal response to endocannabinoids after exposure to severe stress (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26928784
Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26987678
Pharmacological inhibition of FAAH activity in rodents: a promising pharmacological approach for psychological – cardiac comorbidity? (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416300318
Childhood Maltreatment in the Migraine Patient (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27194425
Activation of cannabinoid CB1 receptors in the ventral hippocampus improved stress induced amnesia in rat (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27282634
Exercise as an adjunctive treatment for cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27314543
Docosahexaenoic acid attenuates in endocannabinoid synthesis in RAW 264.7 macrophages activated with benzo(a)pyrene and lipopolysaccharide (abst–2016) http://www.sciencedirect.com/science/article/pii/S0378427416301667
Understanding resilience: New approaches for preventing and treating PTSD (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27417856
Endocannabinoids control vesicle release mode at midbrain periaqueductal grey  inhibitory synapses (abst–2016)  http://onlinelibrary.wiley.com/doi/10.1113/JP272292/abstract
Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616301269
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568641
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27716956
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816304580
Older marijuana users: Life stressors and perceived social support (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27776245
Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives (abst–2016) http://www.jsad.com/doi/10.15288/jsad.2016.77.889
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891602
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302465
Identification of an endocannabinoid system in the rat pars tuberalis-a possible interface in the hypothalamic-pituitary-adrenal system? (abst–2016) http://link.springer.com/article/10.1007%2Fs00441-016-2544-1
Signaling pathways to and from the hypophysial pars tuberalis, an important center for
the control of seasonal rhythms (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/28511899
The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models (abst–2016)  http://www.biologicalpsychiatryjournal.com/article/S0006-3223(15)00532-6/fulltext
Marijuana use in adults admitted to a Canadian epilepsy monitoring unit (abst–2016) http://www.epilepsybehavior.com/article/S1525-5050(16)30334-1/fulltext
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure (full–2017) http://www.nature.com/articles/ncomms14782
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of  Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial  orbital cortex of mice with acute stress (full–2017)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553743/
The Endocannabinoid System Differentially Regulates Escape Behavior in Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655002/
Cannabinoid Modulation of the Stressed Hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742214/
The endocannabinoid gene faah2a modulates stress-associated behavior in zebrafish  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5756047/
Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol
Consumption in Mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777574/
2-Arachidonoylglycerol ameliorates inflammatory stress-induced insulin resistance in  cardiomyocytes (download–2017)  http://www.jbc.org/content/early/2017/03/20/jbc.M116.767384.long
Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28134998
FAAH Inhibition Produces Antidepressant-like efforts of Mice to Acute Stress via Synaptic Long-term Depression (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28193523
Upregulation of fatty acid amide hydrolase in the dorsal periaqueductal gray is associated with neuropathic pain and reduced heart rate in rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28148494
Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model  of social isolation stress (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0361923016303100
Co-localization of the cannabinoid type 1 receptor with corticotropin-releasing factor containing afferents in the noradrenergic nucleus locus coeruleus: implications for the  cognitive limb of the stress response (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28255675
Nutritional status dependent endocannabinoid signalling regulates the integration of rat  visceral information (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28233325
Functional Redundancy Between Canonical Endocannabinoid Signaling Systems in the  Modulation of Anxiety (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0006322317313574
Prefrontal endocannabinoids, stress controllability and resilience: A hypothesis (abst–2017) http://www.sciencedirect.com/science/article/pii/S0278584616302470
Demographic Characteristics, Components of Sexuality and Gender, and Minority Stress  and Their Associations to Excessive Alcohol, Cannabis, and Illicit (Noncan Association Between Plasma N-Acylethanolamides and High Hemoglobin Concentration  in Southern Peruvian Highlanders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28665150
Cannabinoids prevent the differential long-term effects of exposure to severe stress on  hippocampal- and amygdala-dependent memory and plasticity (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28667676
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain  Development (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28685756
Effects of cannabinoid drugs on aversive or rewarding drug-associated memory  extinction and reconsolidation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28729064
Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28745306
The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event (abst–2017) http://www.sciencedirect.com/science/article/pii/S1074742717301284?via%3Dihub
Blunted stress reactivity in chronic cannabis users (abst–2017)  https://link.springer.com/article/10.1007%2Fs00213-017-4648-z
Pharmacological challenge studies with acute psychosocial stress (abst–2017)  http://www.psyneuen-journal.com/article/S0306-4530(17)30544-9/fulltext
Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain  injury to optimize and facilitate clinical translation (abst–2017)
http://www.sciencedirect.com/science/article/pii/S014976341730088X
Stress Promotes Drug Seeking Through Glucocorticoid-Dependent Endocannabinoid  Mobilization in the Prelimbic Cortex (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29100630
Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress (abst–2017) http://www.psyneuen-journal.com/article/S0306-4530(17)30614-5/fulltext
Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28599212
Cognitive, physical, and mental health outcomes between long-term cannabis and  tobacco users (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0306460317304628?via%3Dihub
Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid  expression of innate anxiety and excessive alcohol intake (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29071769
Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent  Patients (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29105663
Attitudes, perceptions, and use of marijuana in youth with multiple sclerosis (abst–2017) https://link.springer.com/article/10.1007%2Fs00415-017-8715-5
Effects of CB1 receptor antagonism and stress exposures in adolescence on  socio-emotional behaviours, neuroendocrine stress responses, and expression of relevant  proteins in the hippocampus and prefrontal cortex in rats (full–2018)  https://www.sciencedirect.com/science/article/pii/S0028390817304963?via%3Dihub
Oxidative burst and Dectin-1 triggered phagocytosis affected by Norepinephrine and  Endocannabinoids – Implications for fungal clearance under stress (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29329391
Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on  mouse corticostriatal circuitries: Implications for neuropsychiatric disorders (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29388323


STROKE*+
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia (full–2010) http://stroke.ahajournals.org/content/41/12/2956.long
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00195.x/full
The development of cannabinoid CBII receptor agonists for the treatment of central  neuropathies (link to download–2010) http://www.eurekaselect.com/85808/article
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke (link to PDF–2010) http://www.mdpi.com/1424-8247/3/7/2197
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment (full–2010) http://www.fasebj.org/content/24/3/788.long
top
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic ischemic brain damage in mice is mediated by CB(2) and adenosine receptors (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19900555
Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia ischemia in newborn pigs (full–2011)  http://www.nature.com/pr/journal/v70/n3/pdf/pr2011171a.pdf
Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury (link to download–2011) http://www.eurekaselect.com/76055/article
Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral ischemia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21443454
Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21145311
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/?tool=pubmed
Update on the role of cannabinoid receptors after ischemic stroke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?tool=pubmed
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection (full–2012) http://stroke.ahajournals.org/content/43/1/211.long
Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446851/
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/full
Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion (full–2012) http://www.jneuroinflammation.com/content/9/1/76
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086494/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Site-specific and time-dependent activation of the endocannabinoid system after  transection of long-range projections (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3310878/?tool=pubmed
Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22119394
top

Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats (abst-2012) https://www.karger.com/Article/Abstract/338755
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001062
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23069763
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury (abst–2012) http://www.sciencedirect.com/science/article/pii/S1043661812001636
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve
remyelination through regulation of the phosphorylation level of the ERK 1/2 via
cannabinoid receptor 1 after stroke-induced demyelination (abst–2012)  https://www.sciencedirect.com/science/article/pii/S0006899312018008
Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a  photothrombotic stroke model (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22895861
Headache after substance abuse: A diagnostic dilemma (abst-2012)  http://www.ncbi.nlm.nih.gov/pubmed/22245279
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12347/full
Is the cardiovascular system a therapeutic target for cannabidiol? (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2012.04351.x/full
Drug-Induced Hypothermia in Stroke Models: Does it Always Protect? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081530/
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury (full–2013) http://ajp.amjpathol.org/article/S0002-9440%2812%2900890-5/fulltext
Ischemic stroke after use of the synthetic marijuana “spice” (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863350/
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575938/
Does smoking marijuana cause stroke? (article–2013) http://www.thepoisonreview.com/2013/01/26/does-smoking-marijuana-cause-stroke/
Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats (abst–2013) http://link.springer.com/article/10.1007/s11064-012-0927-6
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23880371
Acupuncture therapy for stroke patients (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24215922
Effect of cannabinoid CB2 receptor agonism on learning and memory in a mouse model of photothrombosis (abst–2013) http://www.fasebj.org/content/27/1_Supplement/1097.4.abstract?sid=01da6a98-e459-4153-9d22-acca30408ac8
Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: Therapeutic time window, combination with t-PA and efficacy in aged rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23791950
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review  (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22371074
Synthetic Cannabis and Acute Ischemic Stroke (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24119618
Unique effects of compounds active at both cannabinoid and serotonin receptors during stroke (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24323810
top

‘Legal high’ associated Wallenberg syndrome (abst–2013) http://casereports.bmj.com/content/2013/bcr-2013-009693.abstract?sid=0550787d-e463-41b1-bac9-0d2bad5504d9
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway (full–2014) http://www.sciencedirect.com/science/article/pii/S0167488914002821
Cannabinoids in experimental stroke: a systematic review and meta-analysis (full–2014) http://jcb.sagepub.com/content/35/3/348.long
The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0304394014002766
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst–2014) http://www.sciencedirect.com/science/article/pii/S1043661814000814
Severe rhabdomyolysis and intracranial hemorrhage associated with synthetic cannabinoid: a case report (abst in English–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25179201 (abst in Japanese) http://medicalfinder.jp/doi/abs/10.11477/mf.1436102331
A case of acute cerebral ischemia following inhalation of a synthetic cannabinoid (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25241766
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24532152
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine (abst–2014) http://www.sciencedirect.com/science/article/pii/S0041008X14002646 
Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23943518
Host Neuro- Immuno-Endocrine Responses In Periodontal Disease (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24588827

Endocannabinoids modulate human blood-brain barrier permeability in vitro (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459020/ 
Involvement of GluR2 up-regulation in neuroprotection by electro-acupuncture pretreatment via cannabinoid CB1 receptor in mice (full–2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
Time-Dependent Protection of CB2 Receptor Agonist in Stroke (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132487
Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0141600
top
Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558292/
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Pre-clinical Models to Clinical Applications (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552583/
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/jnc.13288/full
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemia reperfusion through activating cannabinoid receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25854559
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System (abst–2015) https://link.springer.com/article/10.1007%2Fs11886-015-0627-3 
Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299059
Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26343919
Endocannabinoids and the Cardiovascular System in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408169
A pathophysiological role of TRPV1 in ischemic injury after transient focal cerebral ischemia in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0006291X15307270
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Endocannabinoids in Cerebrovascular Regulation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865067/
Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under  Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation (full–2016)
http://www.ncbi.nlm.nih.gov/pubmed/27021494
Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408584/
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome  After Stroke (full–2016) http://stroke.ahajournals.org/content/48/1/204.long
Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by  the excess microglia-mediated inflammation (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931157/
Cannabis, Tobacco, Alcohol Use, and the Risk of Early Stroke: A Population-Based Cohort Study of 45 000 Swedish Men (full–2016)  http://stroke.ahajournals.org/content/48/2/265.long
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26778127
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26820826
top
Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820679

Sevoflurane Prevents Stroke-induced Depressive and Anxiety Behaviors by Promoting Cannabinoid Receptor Subtype I-dependent Interaction Between β-Arrestin 2 and ERK1/2 in the Rat Hippocampus (abst–2016)  http://onlinelibrary.wiley.com/doi/10.1111/jnc.13613/abstract;jsessionid=0C6306A98EEF48804178DBCA7B93ECF9.f03t02
Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27142423
Pharmacological hypothermia: a potential for future stroke therapy? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27320243
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27323449 Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305353
Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27425766
Repeated Thrombosis After Synthetic Cannabinoid Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27595371
Acute Effects of Synthetic Cannabinoids: Update 2015 (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27715709
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28042028
CB2 cannabinoid receptors modulate HIF-1α and TIM-3 expression in a hypoxia ischemia mouse model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28253997
β-Caryophyllene/Hydroxypropyl-β-Cyclodextrin Inclusion Complex Improves Cognitive  Deficits in Rats with Vascular Dementia through the Cannabinoid Receptor Type 2-Mediated Pathway (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00002/full
In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke  neuroinflammation in rats: a positron emission tomography study (full–2017)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0851-4
Inflammatory Regulation by Driving Microglial M2 Polarization: Neuroprotective Effects of Cannabinoid Receptor-2 Activation in Intracerebral Hemorrhage (full–2017) http://journal.frontiersin.org/article/10.3389/fimmu.2017.00112/full
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
A randomised controlled cross-over double-blind pilot study protocol on THC:CBD  oromucosal spray efficacy as an add-on therapy for post-stroke spasticity (full–2017) http://bmjopen.bmj.com/content/7/9/e016843.long
Involvement of the endocannabinoid system in the physiological response to transient  common carotid artery occlusion and reperfusion (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248520/
Ischemic stroke associated with the use of a synthetic cannabinoid (spice) (full–2017) http://www.asianjournalofpsychiatry.com/article/S1876-2018(16)30148-4/fulltext
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of  Vascular Dementia (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/
Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke  Prevention (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665427/
Strokes are possible complications of cannabinoids use (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28237318
Neurological aspects of medical use of cannabidiol (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28412918
Fatty acid amide hydrolase (FAAH) regulates hypercapnia/ischemia-induced increases in  n-acylethanolamines in mouse brain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28488728
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of  endocannabinoid system modulation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28497982
N-stearoyltyrosine protects primary cortical neurons against oxygen-glucose deprivation induced apoptosis through inhibiting anandamide inactivation system (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0168010217300123
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor  URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion  model by blocking NF-κB pathways (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28825114
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and  the ugly (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28905873
Activation of cannabinoid receptor 1 is involved in protection against mitochondrial  dysfunction and cerebral ischaemic tolerance induced by isoflurane preconditioning  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29045576
Cannabis Smoking and Cardiovascular Health: It’s Complicated (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28548223
Neuroprotective effects of drug-induced therapeutic hypothermia in central nervous  system diseases (abst–2017)  http://www.eurekaselect.com/152965/article
Stroke and cannabis use in patients with no cardiovascular risk factors: a systematic  review of case reports (abst in English–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29277524 (abst in Spanish)  http://www.elsevier.es/es-revista-neurologia-295-avance-resumen-ictus-consumo-cannabis-pacientes-sin-S0213485317303626
Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two  models of ischemia (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29288767
Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein  Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery  Occlusion and Reperfusion (full–2018) http://www.mdpi.com/1422-0067/19/2/426
Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in rats (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29351454


STURGE-WEBER SYNDROME
Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28454984


STUTTERING +
Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve  Severe Vocal Blocking Tics in Two Patients (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28796166


SUICIDE
Mixed mood disorder (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/228/?pagenum=2
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878847/
Does cannabis use increase the risk of death? Systematic review of epidemiological  evidence on adverse effects of cannabis use (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20565525
Neuropsychiatric adverse effects of centrally acting antiobesity drugs (1st page–2011)  https://www.deepdyve.com/lp/wiley/neuropsychiatric-adverse-effects-of-centrally-acting-antiobesity-drugs-Sy0a9pYcBp
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists (abst–2011) http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147(11)00035-6
Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency (abst–2011)  http://www.sciencedirect.com/science/article/pii/S0278584610004227
High on Life? Medical Marijuana Laws and Suicide (full–2012) http://ftp.iza.org/dp6280.pdf
K2 Toxicity: Fatal Case of Psychiatric Complications Following AM2201 Exposure (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319529/
Suicidal ideation and self-harm following K2 use (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23304900
Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates (full–2014) http://www.futuremedicine.com/doi/full/10.2217/pgs.14.151
Medical Marijuana Laws and Suicides by Gender and Age (abst–2014) http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2013.301612?journalCode=ajph
Cannabis use and suicidal ideations in high-school students (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
Does the legalization of medical marijuana increase completed suicide? (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/24949839
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26253623
A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26331953
Endocannabinoids and Mental Disorders (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_8
top
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment (full–2016) http://journals.lww.com/tnpj/Fulltext/2016/01000/Cannabis_for_posttraumatic_stress_disorder__A.6.aspx

Dose of Reality: The Effect of State Marijuana Legalizations (report–2016) http://www.cato.org/publications/policy-analysis/dose-reality-effect-state-marijuana-legalizations#full
Suicide attempt with a mix of synthetic cannabinoids and synthetic cathinones: Case report of non-fatal intoxication with AB-CHMINACA, AB-FUBINACA, alpha-PHP, alpha-PVP and 4-CMC (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26890319
A multicenter retrospective survey of poisoning after consumption of products containing novel psychoactive substances from 2013 to 2014 in Japan (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27314752
Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed  cannabinoids (full–2017) http://casereports.bmj.com/content/2017/bcr-2017-222059.long
New challenges in toxicology of new psychoactive substances exemplified by fatal cases  after UR-144 and UR-144 with pentedrone administration determined by LC-ESI-MSMS
in blood (full in Polish & English-2017) https://www.termedia.pl/Journal/-82/Artykul-31005
Associations between substance use disorders and suicide or suicide attempts in people  with mental illness: A Danish nationwide, prospective, register-based study of patients  diagnosed with schizophrenia, bipolar disorder, unipolar depression or personality  disorder (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28192643
Cannabis use and the course and outcome of major depressive disorder: A population  based longitudinal study (abst–2017) http://www.psy-journal.com/article/S0165-1781(16)31187-8/abstract
Acute Substance Use as a Warning Sign for Suicide Attempts: A Case-Crossover  Examination of the 48 Hours Prior to a Recent Suicide Attempt (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28682530
Synthetic Cannabis Analogues and Suicidal Behavior: Case Report (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28796120
Death by self-mutilation after oral cannabis consumption (abst–2017)  http://www.legalmedicinejournal.com/article/S1344-6223(17)30258-4/fulltext


SYSTEMIC MASTOCYTOSIS
Systemic mastocytosis and medical marijuana (case report- undated) http://cannabisclinicians.org/view-all-case-reports/entry/645/


SYSTEMIC SCLEROSIS
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893662/
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis (full–2010) http://onlinelibrary.wiley.com/doi/10.1002/art.27642/full
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in  health and disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624216/
Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22033526
Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22492781
Pathogenesis of Systemic Sclerosis (full–2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis? (link to PDF–2016) http://www.ima.org.il/imaj/ViewArticle.aspx?aId=3850
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024


Advertisements